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ABSTRACT OF THE DISSERTATION 
Mechanism of Lmx1b-regulated Limb Dorsalization 
by 
Jennifer Feenstra 
Doctor of Philosophy, Graduate Program in Anatomy 
Loma Linda University, June 2012 
Dr. Kerby Oberg, Chairperson 
 
Lmx1b, a LIM homeodomain transcription factor is necessary for limb, kidney, 
eye, and central nervous system development. Lmx1b knockout (KO) mice display; 
abnormal limb dorsalization with distal ventral-ventral limbs, nephropathy, ocular 
malformations, loss of dopaminergic/serotonergic  neurons, and reduced cerebellum and 
tectum formation. The developmental mechanisms utilized by Lmx1b remain largely 
unknown; to investigate downstream targets, we have used the limb as a model because 
of its accessibility and striking Lmx1b KO phenotype.    
To identify candidate genes, we compared gene arrays from Lmx1b KO and 
wildtype mouse limbs during limb dorsalization, i.e., 11.5, 12.5, and 13.5 days post 
coitum. We identified 54 target genes differentially expressed in all three stages. An 
abundance of extracellular matrix-related targets were found to be regulated by Lmx1b, 
including collagens and proteoglycans.   Three Lmx1b-regulated proteoglycans, are 
clustered together at one genomic locus, Keratocan, Lumican, and Decorin (KLD).  To 
determine whether Lmx1b’s regulation of these targets is direct, we used in silico 
comparative genomic analysis and identified a potential regulatory region with a known 
Lmx1b binding site (Peak 3). We hypothesized that Lmx1b directly regulates KLD via 
Peak 3.  We isolated Peak 3 and linked it to a green fluorescent protein (GFP) reporter. 
xix 
This construct was electroporated into chick embryos at the primitive streak stage 
(Hamburger-Hamilton (HH) 4) and during early neural tube formation (HH10). GFP 
expression was detected in neural tube and surrounding the developing midbrain and 
cerebellum.  Expression of Lmx1b and KLD mRNA overlaps the activity of this 
regulatory region.  
Our data suggests Lmx1b regulates morphogenesis by altering the extracellular 
matrix composition such as KLD proteoglycans.  Furthermore, the activity of KLD-
associated Peak 3 localized to Lmx1b-dependant CNS structures during development 
supports a direct role for Lmx1b regulation. 
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CHAPTER ONE  
INTRODUCTION 
 
 
The Developing Limb 
Around 1 in 600 human newborns present with some form of upper limb 
abnormality (Flatt AE 1977).  Characterization of the molecular pathways that orchestrate 
limb development is essential to understanding the etiology, diagnosis and possible 
interventions for patients with limb malformations. Additionally, the limb is a powerful 
developmental model to examine how patterned structures arise. Therefore, the molecular 
mechanisms which orchestrate limb development have been the focus of intense study for 
several decades.  
During early embryonic development, homeobox (Hox) transcription factors set 
up a segmental body plan along the cranial-caudal axis (Burke, Nelson, Morgan, & 
Tabin, 1995).  Around the fourth week of human development, the presumptive limb 
fields are established, triggering the expression of Tbx5, Wnt and Fgf proteins that 
initiate limb outgrowth (Burke, et al., 1995).  The limb bud emerges as a bulge of lateral 
plate mesoderm covered by a thin outer layer of ectoderm (Fig. 1.1). Following formation 
of the limb bud, development proceeds along three axes:  proximal-distal, anterior-
posterior (radial-ulnar), and dorsal-ventral (Fig. 1.1). 
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Figure 1.1) Limb Bud Coordinate Axes and Signaling Centers 
The forelimb (boxed region, A) of a Carnegie stage 13 (Moore, Hutchins, & O'Rahilly, 
1981) embryo is depicted with the three coordinate axes (B, C), each with their own 
signaling center. The apical ectodermal ridge (AER - orange) coordinates proximal-distal 
(Pr-Di) outgrowth and differentiation.   The zone of polarizing activity (ZPA - purple) 
controls radial-ulnar asymmetry. The dorsal ectoderm (green) regulates dorsal-ventral 
(Do-Ve) asymmetry. Within the FGF responsive zone (FRZ - blue), the fate of 
mesodermal cells are determined by these signaling centers.  The axes and signaling 
centers are shown in different orientations; (B) Dorsal view, and (C) Lateral, end on view  
(Modified from Oberg, Greer, & Naruse, 2004). 
 
 
Formation of the Proximal-Distal and Anterior-Posterior Axes 
 Development and differentiation of each axis is controlled by a population of cells 
that signal patterning information to local cells and organize tissue along its axis, i.e., 
signaling centers.  Mesodermal Fgf10 at the apical dorsal-ventral boundary induces 
ectodermal thickening to form the signaling center for the proximal-distal axis, the apical 
ectodermal ridge (AER) (Zakany, Zacchetti, & Duboule, 2007).  The AER, in turn, 
secretes Wnt3 and several Fgf proteins (Fgf4, 8, 9 & 17), which maintain Fgf10 
expression in the underlying mesoderm.  Fgf10 sustains the proliferation of a sub-AER 
population of cells termed the Fgf responsive zone (FRZ) (Boehm et al., 2010). This 
3 
reciprocal loop of ectodermal and mesodermal Fgf/Wnt proteins maintains proximal-
distal outgrowth (Barrow et al., 2003; Kawakami et al., 2001).   
Development and differentiation along the anterior-posterior (radial-ulnar) axis is 
controlled by the zone of polarizing activity (ZPA) in the posterior (ulnar) limb 
mesoderm.  The ZPA expands limb width and posteriorizes (ulnarizes) the developing 
limb through a secreted morphogen, sonic hedgehog (SHH) (Riddle, Johnson, Laufer, & 
Tabin, 1993).  The AER and the ZPA are closely linked by a reciprocal feedback loop 
that maintains SHH expression adjacent to the distal posterior (ulnar) border of the AER 
during progressive outgrowth (Lee Niswander, Jeffrey, & Martin, 1994; Sun et al., 2000).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2) Molecules Linked to Dorsal-Ventral Limb Development 
Graphic representation of the molecular interactions initiating dorsal-ventral axis 
formation. Wnt7a expression in the dorsal ectoderm is denoted by blue, the boundary 
between dorsal and ventral is demarcated by the green dot (Radical Fringe) and En-1 in 
the ventral ectoderm is orange. Lmx1b expression along the dorsal compartment is shown 
in red, arrow in dorsal compartment indicates Lmx1b induction via Wnt7a. (+ indicates 
the molecule is a dorsalizing factor) 
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Formation of the Dorsal-Ventral Limb Axis 
Patterning of the dorsal-ventral axis begins with delineation of the dorsal and 
ventral limb compartments (Fig 1.2). Initially the secreted protein Wnt7A is expressed in 
the presumptive limb ectoderm. The transcription factor Engrailed 1 (En-1) is induced by 
Bone Morphogenic Proteins in the ventral ectoderm. En-1 restricts Wnt7A expression to 
the dorsal ectoderm, where Wnt7A dorsalizes the underlying limb mesoderm through the 
induction of the Lim homeodomain transcription factor Lmx1b (Riddle et al., 1995; 
Vogel, Rodriguez, & Warnken, 1995).   The role of each of these molecules in dorsal-
ventral patterning is described in further detail below.  
 
Wnt7A 
The Wnt family of secreted proteins is essential for normal limb formation and 
several Wnt proteins are differentially expressed during limb outgrowth. Secreted Wnt7a 
in the dorsal ectoderm upregulates the expression of Lmx1b in the dorsal mesoderm and 
also modulates posterior Shh expression in the ZPA, thereby influencing both anterior-
posterior and dorsal-ventral axis formation. Functional absence of Wnt7a in knockout 
mice causes ventralization of dorsal limb structures, i.e., a ventral-ventral limb with 
footpads on the dorsal autopod surface (Chen et al., 1998; Cygan, Johnson, & McMahon, 
1997). In contrast, misexpression of Wnt7a in the ventral ectoderm induces Lmx1b 
expression in the ventral limb compartment and a subsequent dorsal-dorsal limb 
phenotype (Loomis, Kimmel, Tong, Michaud, & Joyner, 1998). In humans, mutations of 
WNT7A are associated with Fuhrman syndrome or Al-Awadi/Raas-Rothschild/Schnizel 
phocomelia.  Fuhrman syndrome may arise from one or more mutations found in the 
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third exon of WNT7A correlated to bowing of the femoral bone, absent fibula and/or 
ulna, polydactyly, syndactyly, oligodactyly, hyploplastic fingers and fingernails (Woods 
et al., 2006).  Al-Awadi/Raas-Rothschild/Schnizel phocomelia is associated with a 
mutation in the fourth exon of WNT7A associated with a variation of symptoms 
including absence of the ulna, pelvis, uterus and/or fibula or the more pronounced 
anomaly phocomelia (Lonardo, Sabba, Luquetti, Monica, & Scarano, 2007). 
The striking morphological changes in both the Wnt7a KO mouse model and in 
the human studies have established a role for ectodermally expressed Wnt7a as an 
organizer of the dorsal-ventral limb axis with contributions to the anterior-posterior axis. 
Wnt7a is essential for up-regulation of Lmx1b in the underlying dorsal mesoderm, which 
initiates the cascade necessary for limb asymmetry along the dorsal-ventral axis.  
Although Lmx1b conveys dorsal limb fates, the mechanism by which Wnt7a induces 
Lmx1b remains to be shown.  
 
Engrailed-1 
 Engrailed-1 (En-1) is a homeobox transcription factor expressed in the ventral 
ectoderm, which restricts Wnt7a to the dorsal mesoderm. In the mouse, loss of En-1 
allows Wnt7a to maintain its expression in the ventral ectoderm, thereby creating a 
dorsal-dorsal limb phenotype (Loomis, et al., 1998). In contrast loss of Wnt7a does not 
alter or expand En-1 expression and produces a ventral-ventral limb (Parr & McMahon, 
1995). Since cells not under the influence of En-1 produce a ventral morphology, it has 
been suggested that the presumptive limb field is programmed with a ventral 
specification i.e. the default pathway of the limb is ventral (Chen & Johnson, 1999). 
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Therefore, the presumptive limb is specified as ventral until intervention by Wnt7a which 
induces Lmx1b, thereby effectively dorsalizing the limb.  
 
Lmx1b 
Lmx1b is a LIM-homeobox transcription factor comprised of eight exons that 
produce a 7kb mRNA (Dunston, Hamlington, et al., 2004). Exon 7 can be alternatively 
spliced to produce two predicted proteins of 372 and 379 amino acids. It is currently 
unknown if these isoforms have any functional difference. The second and third exon of 
Lmx1b contains two N-terminal LIM-domain regions, characterized by two tandem 
repeats of cysteine/histidine and zinc finger domains. LIM-domains represent potent 
protein-protein interaction motifs and have been studied in many fields including 
cytoskeletal organization, organ development and oncogenesis. Found in exon four, five 
and six is a DNA/RNA binding homeodomain region, which is highly conserved (99%) 
between mouse and human. Using electrophoretic mobility-shift assays it has been shown 
that the Lmx1b homeodomain binds to the FLAT sequences, i.e. FLAT-E (TAATTA) 
and FLAT-F (TAATAAT) (Rohr et al., 2002). Many well-known homeobox transcription 
factors have been characterized as selector genes, which are considered to be or act as 
master switches with the ability to transcriptionally enhance or repress other genes 
(Kuziora & McGinnis, 1988).  
Due to its functionally interactive structure and classification as a selector gene, it 
is not surprising that Lmx1b is essential for the correct development of several organ 
systems. In humans, loss of one Lmx1b allele (haploinsufficiency) causes Nail Patella 
Syndrome (NPS) (Chen, et al., 1998). Although commonly known as NPS this syndrome 
7 
may also be referred to as Onychoosteodysplasia, Turner-Kieser Syndrome, or Fong 
Disease. Mutations of the Lmx1b gene cause NPS and occur mainly within the LIM 
domains (82%) and the homeodomain (18%) (E. M. Bongers, Gubler, & Knoers, 2002), 
enhancing the importance of these regions for Lmx1b function. NPS is an autosomal 
dominant disorder symptoms of which can include nephropathy, open angle glaucoma, 
inhibition of dopaminergic/serotonergic neurons and various skeletal abnormalities 
including absent patella, elbow dysplasia, iliac horns and reduced/malformed nails.  
The Lmx1b gene is highly conserved between mouse and human. To delineate the 
role and mechanism of Lmx1b during development, a functional mouse knockout 
(C57BL/6 background) was generated by replacing the first LIM domain and the 
homeodomain with a neomycin cassette (Chen et al., 1998).  Interestingly, the 
heterozygous mutants (Lmx1b +/-), analogous to the human condition, do not exhibit a 
phenotype.  However, the complete lack of Lmx1b function in these mice (Lmx1b -/-) 
produces NPS-associated organs with a much more severe pathology than seen clinically.   
The examination of NPS patients and generation of the Lmx1b KO mouse model has 
helped to delineate the functional roles for Lmx1b during development.  These roles are 
reviewed below. 
 
Functional Roles of Lmx1b during Development 
Kidney Development 
Renal dysfunction is considered the most life threatening of all the NPS 
symptoms, the homozygous Lmx1b KO mice display severe kidney defects including 
large glomerular leaks along the vasculature causing proteinuria and death (Chen, et al., 
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1998). The glomerulus and surrounding Bowmans capsule make up the basic filtration 
system of the kidney. The glomerulus has a unique basement membrane that forms the 
boundary between the blood and urinary spaces and is flanked by a layer of podocytes.  
The processes extending from podocytes determine the size-selectivity of the filtration 
barrier. Podocytes are responsible for secreting basement membrane components 
including collagens and proteoglycans. Lmx1b directs podocyte differentiation and 
maintenance, thereby enabling formation of the distinct collagen fibril composition of the 
glomerular membrane (Rohr, et al., 2002). Specifically, in the mouse at 13.5 days post 
coitum (dpc), Lmx1b is expressed in presumptive glomerulus and persists in the visceral 
glomerular epithelium into postnatal life. Loss of Lmx1b causes disorganization of the 
glomerular basement membrane and disruption and/or fusion of podocyte processes 
(Morello et al., 2001). The disruption of these layers causes the renal dysfunction seen in 
NPS patients and the Lmx1b KO mouse. In Lmx1b KO mice, there is a decrease in the 
expression of collagen IV types (isoforms) three and four in the glomerular basement 
membrane. Additionally, studies using a podocyte-specific Lmx1b KO mouse 
demonstrate the importance of Lmx1b in initial development and maintenance of 
podocytes in the perinatal mouse (Suleiman et al., 2007). Interestingly, patients with 
Alport Syndrome, which is caused by a collagen gene mutation, develop similar 
nephropathy to NPS patients, further supporting the concept of collagen regulation during 
glomerular basement membrane formation (E. M. Bongers, et al., 2002). 
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Eye Development 
Abnormal ocular structures are not common with NPS patients; however, 
congenital cataract, microcornea and sclerocornea have been noted in the literature. Also 
approximately 50% of NPS patients will develop clinical symptoms of open angle 
glaucoma (Lichter et al., 1997; McIntosh et al., 1998; Mimiwati et al., 2006). In the 
mouse, Lmx1b expression begins around 10.5 dpc in the periocular mesenchyme 
followed by a localization to the anterior eye including corneal endothelium, iris ciliary 
body and trabecular meshwork (E. M. H. F. Bongers et al., 2005; Pressman, Chen, & 
Johnson, 2000). Loss of Lmx1b causes cornea stromal defects and hypoplasia of the iris 
and ciliary body possibly causing an increase in intraocular pressure responsible for the 
open angle glaucoma commonly seen in NPS patients and the Lmx1b KO mouse. 
Together the morphology of NPS patients and the Lmx1b KO mouse demonstrate the 
importance of Lmx1b for establishing of the anterior segments of the eye. 
 
Central Nervous System Development 
A role for Lmx1b during CNS development has also been suggested.  During 
CNS development, the isthmus organizer is a signaling center responsible for midbrain 
and hindbrain formation. In the mouse, Lmx1b is expressed in the isthmus organizer 
beginning at 9 dpc (Guo et al., 2007). In the Lmx1b KO mouse, genes normally 
associated with development of the isthmus are not expressed (Fgf8, Wnt1, En1, En2 and 
Pax2).  Subsequently loss of Lmx1b causes a severe reduction of not only the midbrain 
dopaminergic neurons but also the tectum and cerebellum (Guo, et al., 2007). The tectum 
is part of the midbrain that contains the superior and inferior colliculi responsible for 
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visual and auditory receptors respectively. The cerebellum in Lmx1b KO mice is smaller 
but appears normally patterned indicating that Lmx1b is responsible for growth but not 
patterning of the cerebellum.   
Lmx1b is also responsible for determining serotonergic neurons of the hindbrain 
(Y. Ding et al., 2003). Loss of serotonergic signaling is thought to contribute to several 
mental disorders including anxiety, depression, addictions, and post-traumatic stress. 
Correspondingly, NPS patients seem to be predisposed to attention deficit hyperactivity 
disorder and major depressive disorder, although they have normal intelligence with no 
apparent learning disorders (Lopez‚Arvizu et al., 2011).  
Lastly, Lmx1b is expressed in the dorsal interneurons of the spinal cord where it 
contributes to assembly of pain circuitry and differentiation/ migration of sensory 
neurons/afferent fibers (Y. Q. Ding et al., 2004). In the Lmx1b KO mouse, no synaptic 
contacts are formed between the dorsal horn neurons and nociceptive afferent neurons 
responsible for pain response (Y. Q. Ding, et al., 2004). Similarly, NPS patients 
experience neurological deficits such as diminished pinprick sensation and tingling or 
numbness in the limbs (Dunston, Reimschisel, et al., 2004). 
 
Limb Development 
Lmx1b is robustly expressed in the dorsal mesodermal compartment of the 
developing limb. In the mouse, strong Lmx1b expression can be detected in the dorsal 
compartment at 10.5 dpc. With stage progression, Lmx1b expression fades in the 
proximal tissue but remains strong in the distal limb/ autopod until 15.5 dpc (Riddle, et 
al., 1995; Vogel, et al., 1995). NPS patients demonstrate a disruption of dorsal limb  
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Figure 1.3)  Autopod Architecture in WT and Lmx1b KO Mice 
Scanning electron micrographs of the external architecture of - A) wild type (WT) and B) 
Lmx1b knockout (KO) autopods.  A’) The tendon architecture in a digit from a WT 
mouse with normal dorsal-ventral asymmetry.  B’) In a digit from an Lmx1b KO mouse 
the dorsal tendons are ventralized.  – lumbricals (LM), dorsal interosseous (IO), dorsal 
hood (DH), proximal interphalangeal (PIP) joint, metacarpal phalangeal (MP) joint, 
extensor digitorum communis (EDC), flexor digitorum sublimes (FDS), flexor digitorum 
profudus (FDP); LM’, FDS’, and FDP’ indicate ventralized “dorsal” tendons. 
(A/B Adapted from Chen et. al. 1998, A’/B’ Dr. Takuji Naruse unpublished data) 
 
 
 
structures such as the patella and nails (Vollrath et al., 1998) while the Lmx1b KO mouse 
limb displays a complete loss of distal symmetry with ventral-ventral morphology of the 
joints, tendons, limb musculature and nerves (Chen, et al., 1998) (Fig 1.3). 
 Lmx1b is essential for normal dorsal-ventral limb axis formation. Loss of Lmx1b 
causes distal ventral-ventral limb symmetry while overexpression of Lmx1b forms 
dorsal-dorsal structures (Chen & Johnson, 2002; Cygan, et al., 1997; Loomis, et al., 
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1998) indicating Lmx1b is both necessary and sufficient for distal limb dorsalization. 
Additionally, recent fate mapping experiments in the chick and mouse (Arques, Doohan, 
Sharpe, & Torres, 2007; Pearse, Scherz, Campbell, & Tabin, 2007; Qiu, Chen, & 
Johnson, 2009) have shown Lmx1b-expressing cells create or define the dorsal limb 
compartment.  Moreover, while Lmx1b does not initiate compartment formation it is 
essential for dorsal compartment maintenance and dorsal morphogenesis.  
Collectively, these data indicate that Lmx1b is responsible for limb dorsalization, 
however, the mechanism and downstream targets remain to be determined.  Thus, the 
underlying objective of this study is to discover the mechanism of Lmx1b-regulated 
limb dorsalization. 
 
Dissertation Hypothesis 
Based on the evidence from literature, I hypothesized that Lmx1b dorsalizes the 
limb by modifying the expression of genes involved in the formation of joints, 
ligaments, tendons and bones.  I investigated this hypothesis through the following 
specific aims.  
 
Project Specific Aims 
Specific Aim 1.) Identify Genes in the Dorsal Mesoderm Regulated by 
Lmx1b During Limb Development 
Rationale and Approach 
Haploinsufficiency of Lmx1b in Nail Patella Syndrome (NPS) patients and 
complete loss of Lmx1b in the KO mouse indicate the significance of Lmx1b to pattern 
the dorsal tissues of the limb. However, downstream Lmx1b targets in the limb are 
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currently not well characterized. Thus, my working hypothesis was that Lmx1b altered 
downstream skeletal and soft tissue targets, causing asymmetrical limb patterning.  
To examine this hypothesis and discover potential Lmx1b gene targets, we used 
microarray analysis and compared Lmx1b KO mice to wildtype littermates. Specifically 
we targeted stages during limb dorsalization and limb tissues with robust Lmx1b 
expression (11.5-13.5 dpc). Genes differentially expressed in the microarray analysis 
were validates with Real-time PCR. Additionally, whole mount in situ hybridization 
(WMISH) was performed to determine the corresponding tissue pattern of expression for 
the validated Lmx1b target genes.  
 
Outcomes 
Targets discovered that were differentially expressed in the microarray, validated 
by Real-time PCR and asymmetrically expressed along the dorsal-ventral axis included a 
variety of genes ranging from angiogenesis to skeletal formation. Interestingly, a 
significant portion of genes discovered were extracellular matrix molecules such as 
Collagen11a2, Collagen9a3, Aggrecan, Lumican, Decorin, Keratocan. We also 
discovered several genes that are known to associate with or accentuate proteoglycan 
function including Matrilin1, Matrilin4 and Lysyl oxidase. From these findings I 
concluded that Lmx1b may function to regulate extracellular matrix composition, thereby 
patterning developing tissues. See chapter three for the detailed description and 
discussion of these experiments published in Development, Growth, and Differentiation. 
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Specific Aim 2.) Determine Direct Induction of Downstream Lmx1b 
Targets 
Rationale and Approach 
I consider genes discovered in Specific Aim 1 to be downstream Lmx1b targets, a 
preponderance of which are extracellular matrix molecules. The discovery of multiple 
extracellular matrix molecules suggests that Lmx1b dorsalizes the limb, at least in part, 
by changing extracellular matrix composition. Among these extracellular matrix 
molecules were four proteoglycans, three of which (Keratocan, Lumican, Decorin) were 
dorsally expressed in the mouse limb at 12.5 dpc. Thus, my working hypothesis was that 
Lmx1b directly regulates the proteoglycans: Keratocan, Lumican and Decorin.  
To confirm this direct relationship, we chose to use the chick as a bioassay 
because of its accessibility and our ability to focally manipulate gene expression.  We 
successfully developed an avian retroviral construct, which expresses human Lmx1b.  In 
addition, we used an electroporation technique to focally express the construct in the 
ventral wing mesoderm of the chick and induce dorsalization of ventral tissues. (see 
Chapter 2).   
However, when I performed WMISH using Keratocan, Decorin and Lumican in 
the chick, I discovered that these targets, which are dorsally-restricted in the mouse, are 
expressed in the dorsal and ventral wing mesoderm. Thus, native expression of 
Keratocan, Lumican, and Decorin in the chick wing was different from the mouse and 
would impair our ability to determine up-regulation via our humanLmx1b construct. 
Thus, we abandoned the chick as a bioassay to demonstrate direct Lmx1b regulation of 
these proteoglycans as originally planned.  Instead we reported these unique differences 
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in expression and refocused our energies on other techniques to determine direct Lmx1b 
regulation as outlined in Specific Aim 3.  
 
Outcomes 
Many developmental pathways are conserved across vertebrate species.  Thus, 
this disparate expression between chick and mouse was not expected.  To clarify this 
discrepancy, we performed a detailed temporal and spatial expression pattern analysis of 
these proteoglycans (Decorin, Lumican and Keratocan) during dorsalization, comparing 
both forelimbs and hindlimb in the chicken and mouse models.   Our analysis 
demonstrated a marked species-specific difference in the expression patterns of these 
proteoglycans. We also included Aggrecan which is expressed in proliferating 
chondrocytes and is conserved between chick and mouse. Our publication describing this 
disparate proteoglycan expression pattern is detailed in chapter four.  
 
Specific Aim 3.) Determine the Mechanism by which Lmx1b 
Regulates Direct Downstream Targets 
Rationale and Approach 
New sequencing technologies have allowed the field of genetics to flourish. 
Furthermore, new sequences from evolutionarily diverse species are being added to 
public databases regularly. This has created new opportunities to compare evolutionary 
gene changes across species which may correspond to function. In particular, we are 
interested in the discovery of noncoding sequences that participate in gene regulation 
called cis-regulatory regions. These regulatory regions can lie nearby or significantly 
up/downstream of their target genes (Gomez-Skarmeta et al., 2006; Pfeifer et al., 1999) 
16 
Regulatory functions that are conserved across species typically maintain these non-
coding sequences and appear to evolve more slowly than associated coding sequences 
(Blanchette and Tompa, 2003). To identify these conserved noncoding regions (CNRs), 
we used VISTA Genome Browser (http://pipeline.lbl.gov/cgi-bin/GenomeVista, Kent et 
al.,2002;Frazer et al., 2004 ).  VISTA compares the human genome to many diverse 
species and indicates areas of conservation in increments of 100bp intervals.  For our 
analysis we used dog, mouse, opossum, and chicken. We initially examined Keratocan 
since it revealed the greatest fold-change in the microarray analysis and WMISH of 
Keratocan was undetectable in the Lmx1b KO mouse limb. When we examined the 
location of Keratocan on the genome, we recognized that Lumican and Decorin lie just 
upstream (5’) of Keratocan.  We referred to this cluster of three proteoglycan genes as the 
KLD locus. Additionally, 5’ to the KLD locus is a 900kb gene desert, a region devoid of 
protein coding genes. When searching for conserved sequences, gene deserts have been 
shown to be regions rich in regulatory elements. VISTA analysis produced 12 CNRs 
surrounding the KLD locus. Using more detailed genomic alignment, we discovered two 
of the CNRs, Peak3 and Peak10, contain FLAT sequences (potential Lmx1b binding 
sites) which are conserved across the multiple species we examined. Thus, my working 
hypothesis for this specific aim was that Lmx1b binds to its specific binding site 
(FLAT sequence) within Peak3 and Peak10 to directly regulate Keratocan, Lumican 
and/or Decorin.  
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Outcomes 
Peak3 and Peak10 constructs were electroporated into the primitive streak stage 
chick embryo and allowed to incubate to HH14 to determine activity. Peak10 showed no 
activity in the early embryo but Peak3 showed activity in the neural tube and developing 
brain vesicles beginning around HH10. Later CNS targeted expression of Peak3 reveals 
activity surrounding the developing brain vesicles at HH19/20. Isolation and 
overexpression of the FLAT binding site in the developing brain also shows activity 
indicating the FLAT site may be the region necessary for Peak3 activity. Together we 
believe this indicates that Lmx1b uses the FLAT site of Peak3 to direct KLD expression 
in the developing brain. Data acquired to support this aim is presented in chapter 5. 
Peak3 and Peak10 were also electroporated into the presumptive limb at HH14 
and monitored for GFP every 24 hours from HH19-HH25. However no activity was 
detected for Peak3 or Peak10 in the chick limb.  
 
Specific Aim 3.) Alternate Strategy 
Rationale and Approach 
 In addition to the identification of regulatory regions using software methods, 
newly developed next generation sequencing techniques have not only emerged but have 
now become affordable. The combination of next generation sequencing and chromatin 
immunoprecipitation (ChIP-seq) is a powerful tool to examine DNA-protein interactions.  
Our goal is to use ChIP to isolate Lmx1b-bound chromatin during limb development, 
when Lmx1b is expected to interact with DNA to actively regulate transcription 
responsible for dorsalization (12.5dpc).  At 12.5 dpc limbs are harvested and fixed using 
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formaldehyde to reversibly cross-link DNA-protein complexes.   The chromatin is then 
fragmented and combined with a high affinity Lmx1b antibody.  The chromatin bound to 
Lmx1b is isolated and purified for sequencing. For our experiments, a high affinity 
Lmx1b antibody is available (Suleiman, et al., 2007).  However to implement ChIP-seq a 
significant challenge remains, a direct downstream target that will act as a positive 
control is important for optimization. Currently the only reported direct downstream 
targets of Lmx1b are in the kidney.  
In the kidney, podocytes secrete basement membrane components including 
collagens and proteoglycans. Lmx1b directs podocyte differentiation and maintenance, 
and loss of Lmx1b causes aberrant basement membrane formation, thereby preventing 
normal glomerular filtration (Rohr, et al., 2002). Two genes have been implicated as 
direct downstream Lmx1b targets in the kidney: Col4a4 and Nphs2 (Rascle et al., 2009).  
The disruption of renal morphology in the Lmx1b KO mouse, suggests that kidney 
development is similar to limb development, with Lmx1b regulating extracellular matrix 
during morphogenesis. Therefore, we believe targets discovered in embryonic kidney 
cells using ChIP-seq may overlap with, and also expand, our understanding of Lmx1b-
mediated limb patterning. We hypothesize that Lmx1b regulates Keratocan, Lumican 
and Decorin (KLD) by binding to predicted CNRs of the KLD locus during 
development. 
 
Outcome from Alternate Strategy 
 Human Embryonic Kidney (HEK) cells have been grown in culture and 
transfected with an Lmx1b-hemagglutinin (HA) tagged construct.   Lmx1b-HA cells were 
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harvested to extract DNA, RNA and nuclear protein. We successfully amplified Lmx1b, 
Col4a4 and Nphs2 from HEK RNA and the FLAT site of Col4a4 and Nphs2 from HEK 
DNA by PCR. We also successfully detected enhanced Lmx1b protein levels in Lmx1b-
HA transfected HEK cells by Western blot. Since we determined the HEK cells 
mimicked in vivo conditions, we continued with the ChIP-it Express Enzymatic kit from 
Active Motif.  Using the HA antibody, we were able to isolate Lmx1b-HA-bound 
chromatin and subsequently confirmed the presence of the FLAT sequence by PCR. 
However, we have had trouble immunoprecipitating enough chromatin for sequencing 
purposes. Lmx1b may be a low abundance molecule so we will need to perform multiple 
ChIP runs with a high number of cells. The progress of this alternative approach is 
detailed in chapter 6. 
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CHAPTER TWO 
MATERIALS AND METHODS 
 
 
Specific Aim 1 Methods 
Lmx1b Mouse Model  
The Lmx1b KO mouse was generated by Randy Johnson (Chen, et al., 1998). The 
homeodomain and first LIM domain of the Lmx1b gene was conditionally knocked out 
by inserting a neomycin cassette using the C57BL/6J mouse background. Males and 
females are housed in separate cages with individual ventilation. Colony is maintained by 
mating Lmx1b (+/-) males with Lmx1b (+/+) females, additionally new C57BL/6J 
unrelated virgin females are ordered from Charles river every four months to maintain 
genetic diversity of the colony. Time dated matings use heterozygous (Lmx1b +/-) males 
mated with heterozygous females to obtain homozygous Lmx1b mutant or KO embryos 
(Lmx1b -/-) and wildtype littermates (Lmx1b+/+). For colony maintenance matings male 
(+/-) and female (+/+) mice were housed together for 14 days then separated to allow 
female to deliver pups. For time dated matings female mice were placed in the male cage 
for a 12 hour period, from 7pm to 7am with females checked in the morning for vaginal 
plugs to confirm copulation. Noon on the day the vaginal plug was identified was 
considered as 0.5 days post coitum (dpc). Pregnancy was determined by weighing 
females on day 7 to determine a baseline weight then repeated on days 10/11/12/13 
depending on stage required. Pregnant females on average will gain 1 gram per day, older 
females with bladder problems can show sporadic weight gain, which does not increase 
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over time. Colony Pups were weaned at four weeks after which tail snips were taken to 
perform genotyping. Mice are anesthetized with Isoflurane in a closed chamber (200 μl/ 
750 ml) for 30 seconds. Approximately 1cm of the tail tip is removed and diced with a 
sterile razor blade. Mouse tails are dipped in hemostatic powder to decrease bleeding then 
placed back in cages and observed to ensure proper recovery from anesthesia. Diced tail 
specimens are placed into 750 μl tube containing 250 μl of QuickExtract DNA extraction 
solution (EPICENTER). Tails are vortexed for 15 seconds and incubated 6 minutes at 
650C, vortexed again and incubated for 2 minutes at 980C. 5 μl of this solution was used 
for PCR genotype analysis, primers used demonstrate the presence or absence of the 
Neomycin (Neo) cassette inserted into the Lmx1b gene. Mice containing the Neo cassette 
on both alleles are labeled mutants (-/-), one Neo copy are heterozygous (+/-), and normal 
mice with no Neo insert are wild type (+/+). PCR parameters are as follows: 
950C/5min (1cycle), 950C/15sec, 600C/30sec,720C /45sec (30cycles), 720C/7min 
(1cycle), 40C ∞. Following timed matings pregnant females are anesthetized the day of 
harvesting in the closed container with isoflourane. Females are sacrificed using cervical 
dislocation after which embryos are rapidly removed under sterile conditions. Embryos 
are removed from their gestational sac and placed in 1% phosphate buffered saline (PBS) 
to continue cleaning. Heads were placed in QuickExtract DNA extraction solution 
(EPICENTER) and used for genotyping in the same manner as tail snips. The digestive 
tract, heart and urogenital tract are removed from embryos followed by overnight 
incubation in MEMFA (0.1 mol ⁄L 3-(N Morpholino) propanesulfonic acid (MOPS), 2 
mmol ⁄ L ethylene glycol tetraacetic acid (EGTA), 1 mmol ⁄ L MgSO4, 3.7% 
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formaldehyde) at 40C.  Following fixation embryos are rinsed in PBS and stored in 90% 
Methanol at -200C. 
 
Microarray Analysis 
Lmx1b is a transcription factor utilized during the development of multiple organ 
systems. In 1998, Col4a4 was discovered as a direct downstream target of Lmx1b in the 
kidney. With this discovery it was thought that further determination of the Lmx1b 
cascade would be imminent. However since that discovery nearly 14 years ago only one 
additional direct downstream kidney target has been discovered (Nphs2). In order to 
elucidate previously undiscovered downstream Lmx1b targets in the limb we utilized a 
Lmx1b KO mouse model in conjunction with microarray analysis.  Limbs were analyzed 
during stages of initial tissue differentiation and Lmx1b expression using the Affymetrix 
GeneChip® Mouse Genome 430 2.0 array.  This array is a comprehensive analysis of the 
mouse genome utilizing a powerful probe set of eleven mismatched oligoneucleotide 
probes per transcription sequence for over 39,000 transcripts and variant sequences. Mice 
were time-mated and embryos were harvested at 11.5, 12.5 and 13.5 days post coitum 
(dpc). Embryos were placed in 1% PBS, heads were used for genotyping and limbs were 
removed and stored in RNAlater (Ambion) at -800C. We harvested RNA from Lmx1b 
+/+ and -/- littermate limbs using the RNeasy kit from Qiagen. We modified the protocol 
slightly using three freeze thaw reactions with liquid nitrogen to crush the tissue. Buffer 
RLT including 1ul/100ul B-Mercaptoethanol was added to tissue followed by a 10 min 
incubation at room temperature before spinning in QIAshredder column. Final elution 
was performed twice, 15ul each elution.  RNA utilized was obtained from at least three 
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separate litters producing three unique forelimb sets pooled together to minimize 
biological variability. RNA was quantified with nanodrop spectrophotometer and around 
12 μg was sent to University of California Irvine (UCI Genomics) where RNA and 
microarray analysis was completed.  
 
 
Figure 2.1) RNA Analysis done by UCI on 11.5 dpc Samples 
An example of the RNA analysis done by UCI shows RNA sent in by our lab in Lanes 
labeled 1-4 and RNA sent in from other labs in lanes 5-7.  Lanes 1-2 are wildtype RNA 
Lanes 3-4 are Lmx1b Knockout RNA. 
 
 
 
Microarray data were received and uploaded to Comprehensive R based 
Microarray Analysis web frontend (CARMAweb, 
https://carmaweb.genome.tugraz.at/carma/). CARMAweb simplifies the statistical 
programs R and Bioconductor to normalize and quantify fold-change and significance. 
Data for each gene chip was normalized using JustRMA.  Fold-change and significance 
were determined using the Limma package which preforms a moderated t-test, since we 
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used two chips per group this was the most powerful statistical analysis, since it corrects 
for possible sampling error. Note that chips for each stage were treated as replicates, for 
example 11.5 dpc WT1 and WT2 data was normalized individually then treated as a 
replicate data set to determine fold change and significance. Output analysis from 
CARMAweb is annotated with Affymetrix probe data and can be easily exported to 
Excel, any genes which display a significance of less than 0.005 were removed from 
further analysis. The Excel document was searched to discover genes represented in more 
than one array. Many genes were discovered in multiple arrays including genes up-
regulated at one stage and down-regulated in the next. However, for the purpose of this 
study, we focused on genes up-regulated or down-regulated in all three stages since these 
should represent Lmx1b specific targets rather than stage specific targets. The list of 
genes discovered at all three stages was cross-referenced with literature and genes that 
were sex specific were discarded.  
  
Real-time PCR 
Possible downstream target genes were analyzed by Real-time PCR to validate 
microarray gene expression. Primers were generated for each gene target using 
Sequencher 4.6, each primer set met several parameters including: an annealing temp 
near 600C, 16-22bp length, GC clamp on 5’ and 3’ end, produces a amplicon of 50-
150bp. Primers were tested using mouse limb +/- cDNA libraries, resulting PCR was 
purified and sent out for sequence analysis to determine primer specificity. Primers which 
produced more than one amplicon were discarded. Real-time PCR was performed using 
the Roche Lightcycler 2.0 and Roche recommended sybergreen mastermix reagents. 
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Runs were standard for all target genes beginning with denaturation (950C for 5 minutes), 
amplification 40 cycles (950 for 10seconds, 600 for 10 seconds, 720 for 10 seconds-data 
acquisition), melting curve (950C for 10 seconds ramping at 0.1 degrees/sec continuous 
acquisition). Melting curves were performed following RT runs to determine product 
specificity. Lightcycler software was used to determine WT and KO fold change using 
phosphoglycerate kinase (PGK) control samples to normalize gene expression (Crossing 
point data) for each run.  Each run was performed a minimum of 3 times, standard 
deviation for each was calculated with Excel to create bar graph error bars found in figure 
3.3. 
 
Whole Mount in situ Hybridization 
Primers were generated using the same parameters to pull down 700-1000bp 
probe sequences in the chick and mouse models. Sequences were isolated and cloned 
using the pCRTM II-TOPO (Invitrogen) vector. Constructs were screened for insert and 
grown up overnight to perform Qiagen Miniprep, constructs with insert were sent for 
sequencing to determine sequence fidelity. Sequences with few or no mutations are 
isolated with PCR, then T7 is linked to PCR fragment using the Block-it kit by 
Invitrogen. The linkage of T7 allows for a second PCR of both sense and antisense 
strands using T7 and either the 5’ or 3’ gene specific primers. PCR products are purified 
(Quiagen) and concentration is determined with the nanodrop spectrophotometer. Sense 
and Antisense strands (1 μg) are transcribed using T7 enzyme in conjunction with a 
Digoxigen labeled UTP to create the final Dig-labeled riboprobe (Block-it kit, 
Invitrogen). Probes are treated with DnaseI and purified using Pellet Paint (Novagen). 
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Probes were then heated to 75°C for 10 minutes placed on ice and diluted in cold 
hybridization buffer to 10 ug/ml. 
To determine 3-dimensional gene expression we utilized whole mount in situ 
hybridization (WMISH) with digoxigenin-labeled riboprobes as previously described 
(Yamada et al.,1999). Sterile reagents were made aloquated and frozen to ensure 
cleanliness. Protienase K reactions were 30 min for 11.5dpc mice and HH 23 chick and 
45min for 12.5-14.5 dpc mice and HH 23-29 chick. Hybridization of the transcribed RNA 
probes was carried out at 60°C with stringent post-hybridization washes at 65°C. Sense 
probes were also generated and tested to verify antisense probe specificity. Embryos were 
checked every 20 minutes during colorization to ensure optimal probe staining then 
washed with PBS, fixed in MEMFA and stored in 90% Methanol. We expect that genes 
with confirmed differential expression overlapping Lmx1b expression during limb 
development will be considered downstream targets. A minimum of two expression 
pattern WMISH runs was done in both the chick and mouse using both upper or lower 
limbs to establish a baseline expression pattern.  
 
Specific Aim 2 and 3 Methods 
Chick Model 
Further studies of downstream Lmx1b targets were performed using the chick model 
system. The chick is a longstanding invaluable model for limb development research 
allowing researchers to perform in ovo experiments such as transplantations and AER 
removal. These types of historic experiments have producing data, which substantially 
increased our understanding of how the limb develops. The reasons for the chick model 
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systems popularity include the ability to harvest sufficient numbers of chick embryos at 
precise stages but most importantly the chick is readily accessible in the egg throughout 
development.  
For all experiments using chick embryos fertilized white leghorn chick eggs 
(Chino Ranchers, CA) were incubated at 39°C in a standard humidified avian incubator.   
Depending on the type of electroporation or harvesting the eggs were windowed and 
staged according to Hamburger and Hamilton (HH,Hamburger & Hamilton, 1951).  
WMISH of Lmx1b targets was also performed using comparable staged chick 
embryos. Similar to mouse the chick embryos were harvested in phosphate buffered 
saline, fixed in MEMFA overnight at 40C and stored in 90% Methanol at -200C. 
 
Electroporation Studies 
The accessibility of the chick limb means it can be surgically manipulated, 
electroporated and/or treated with chemicals/proteins. In particular we use several 
different types of electroporation in conjunction with two different vector delivery 
systems. The first vector used is the pTK-EGFP which contains the the f1 phage origin; 
an upstream SV40; a multiple cloning site (MCS); the Herpes simplex virus thymidine 
kinase minimal promoter; an enhanced GFP reporter gene; and the ampicillin resistance 
gene (Uchikawa et al., 2004). Plasmids were isolated from E. coli using the Qiagen 
EndoFree Plasmid Maxi Kit to minimize lipopolysaccharide-related cytotoxicity and 
improve transfection efficiency in chick embryos. The blank pTK-EGFP construct was 
used as a negative control. The second vector system is an avian specific retroviral 
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system RCASBP(A). This vector is replication competent, ampicillin resistant and 
contains a ClaI insertion site (Hughes et al., 1987).  
Whole embryo EP done at Hamburger-Hamilton (HH) stage 4, transfects the 
entire embryonic disc just as it is begins gastrulation. Embryos can be followed in culture 
for 48hrs up to HH14. Therefore electroporation of DNA at HH4 allows for screening of 
DNA activity in early chick development. First embryos are harvested from the egg by 
clearing albumin using the blunt end of forceps then a 2x2 cm Whatmans filter paper 
with a 1cm hole punched in the center is placed onto the Vitelline membrane with the 
embryo in the center of the punched hole. The filter paper is cut from the yolk and excess 
yolk is removed with Hanks Buffered Salt Solution. The embryo is placed on a silicone 
support with a 2mm deep well containing a 2 x 2 mm platinum cathodal electrode (see 
Fig 10). Using a glass capillary pulled-needle, a mixture of the construct plasmid (1μg) 
and Fas-green dye to visualize delivery is injected in the space between the vitelline 
membrane and the excised embryo. The anodal electrode is held above the embryo by a 
micromanipulator with a 3mm inter-electrodal space. HBSS is used between the electrode 
and the embryo to ensure electrical conductivity. The reporter plasmids are driven into 
the embryo by 5 pulses of 5 V for a duration of 50 ms at 100 ms intervals using a CUY21 
electroporator (Protech International, Austin, Texas). Following electroporation embryos 
are incubated on a yolk agar plate in a humidified chamber at 370C. Construct activity 
measured as fluorescent GFP is visualized with fluorescent microscopy and imaged at 24 
and 48hrs.  
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Figure 2.2) Apparatus for Whole Embryo Electroporation at HH4 
Upper panel, silicone support and micro-manipulators used for precise delivery of 
plasmid and stable upper electrode placement. Lower panel, embryo on silicone support 
showing needle with plasmid/phenol red marker at needle tip. The electrode is placed 
over the embryo in contact with buffer solution. 
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HH 10 EP was performed to determine construct efficacy in the brain. Embryos 
were staged and stained with neutral red to facilitate removal of the vitelline membrane 
surrounding the head and electroporation. DNA (1 μg) was injected into the neural tube 
lumen and pushed cranially toward the tip of the anterior neural pore.  Electrodes are 
0.5mm in diameter and are placed on either side of the head approximately 4mm apart 
delivering 3 pulses of 50 ms at 10 V at 100 ms intervals. Embryos are incubated and 
imaged with fluorescent microscopy at 24 and 48 hours to determine construct activity.  
Targeted regional electroporation at HH14 was directed to transfect the lateral 
plate mesoderm thereby introducing DNA into the entire presumptive limb.  Briefly, eggs 
are windowed and embryos stained with neutral red to determine somite number. The 
vitelline membrane overlying the limb is removed and a small slit cut on the yolk 
membrane near the heart. Two platinum electrodes (0.3 mm diameter, at 2.5 mm 
distance) are mounted on a micromanipulator and positioned parallel to the embryo. The 
cathode is placed through the slit and into the yolk. Using a glass capillary pulled-needle, 
a mixture of the regulatory-construct plasmid (2 μg/μL) and fas-green are injected into 
the embryonic coelom underlying the right lateral plate mesoderm. The anode is placed 
above the embryo and 3-5 drops of PBS are used to ensure conductivity. Electroporation 
(EP) was performed with 3 pulses of 50 ms at 8 V at 100 ms intervals. Following surgery 
embryos can be imaged for construct activity and/or incubated for 10 days allowing 
formation of the presumptive skeletal structures. We utilized TREP to test the limb 
dorsalization properties of an RCASBP(A) vector expressing hLmx1b.  Overexpression 
of our RCASBP-hLmx1b construct successfully produced feather buds on the ventral 
limb surface. 
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Figure. 2.3)  Dorsalization of the Chick Limb using the RCASBP-hLmx1b 
Construct 
The chick wing was electroporated at HH14 along the lateral plate mesoderm to 
overexpress Lmx1b in the entire limb. 
 
 
We also perform a focal limb electroporation technique using HH21/22 embryos.  
The Vitelline membrane is removed around the limb and a small amount of fluid is 
removed then limbs can be flipped to expose the ventral surface. A bolus of 1μl 
containing 1 μg of DNA is injected into the limb mesoderm. Electrodes are placed on 
either side of the limb with fluid placed on top to ensure conductivity. Focal 
electroporation is performed with 3 pulses of 50 ms at 50 V at 100 ms. Below is an 
example of our focal electroporation technique using the RCASBP-hLmx1b expressed on 
VentralDorsa
Experimental limb
Control limb
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the ventral limb surface. Embryos were incubated for 48 hours and harvested to 
performed hLmx1b expression WMISH.  
 
 
 
Figure 2.4) Focal Electroporation of RCASBP-hLmx1b into the Ventral Wing 
Mesoderm 
Whole mount in situ hybridization probing for hLmx1b in the chick wing. Expression is 
absent from the control limb and can be seen in the ventral mesoderm of the experimental 
limb.  
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Abstract 
Lmx1b is a homeodomain transcription factor that regulates dorsal identity during 
limb development. Lmx1b knockout (KO) mice develop distal ventral-ventral limbs. 
Although induction of Lmx1b is linked to Wnt7a expression in the dorsal limb ectoderm, 
the downstream targets of Lmx1b that accomplish limb dorsalization are unknown. To 
identify genes targeted by Lmx1b, we compared gene arrays from Lmx1b KO and 
wildtype mouse limbs during limb dorsalization, i.e., 11.5, 12.5, and 13.5 days post 
coitum.  
We identified 54 target genes differentially expressed in all three stages.  Several 
skeletal targets, including Emx2, Matrilin1 and Matrilin4, demonstrated a loss of scapular 
expression in the Lmx1b KO mice, supporting a role for Lmx1b in scapula development. 
Furthermore, the relative abundance of extracellular matrix-related soft tissue targets 
regulated by Lmx1b, such as collagens and proteoglycans, suggests a mechanism which 
includes changes in the extracellular matrix composition to accomplish limb 
dorsalization.  
Our study provides the most comprehensive characterization of genes regulated 
by Lmx1b during limb development to-date and provides targets for further investigation.  
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Introduction 
 The limb is a complex organ that requires unique multi-axis asymmetry for 
function.  The limb emerges from the lateral plate mesoderm as a bulge of 
undifferentiated mesoderm covered by ectoderm.  In the mouse model at 11.5 days post 
coitum (dpc) the limb bud mesoderm is diffuse and relatively uniform. Centrally, the 
mesoderm condenses to form cartilage anlagen and peripheral mesoderm condenses to 
form tendon precursors.  Joint segmentation begins as a zone of high cell density (an 
interzone) within the mesodermal condensation (Craig, Bentley, & Archer, 1987; 
Dalgleish, 1964).  The joint capsule and associated ligaments and tendon attachments 
develop from condensations surrounding the interzone regions (Mitrovic, 1978).  This 
process proceeds in a proximal-to-distal fashion.  By 13.5 dpc, the skeletal elements, 
joints, ligaments and tendon precursors of the stylopod (humerus/femur), zeugopod 
(radius-ulna/tibia fibula) and autopod (hand/foot) are largely defined. 
 Development of the limb bud can be described along three axes. The proximal-
distal axis depicts the progressive outgrowth of the three limb segments: stylopod, 
zeugopod and autopod.  The anterior-posterior axis defines the patterning of the digits 
(e.g., from thumb to little finger) and zeugopod (e.g., radius and ulna).  The dorsal-
ventral axis delineates the extensor and flexor compartments of the limb. The limb has 
marked asymmetry in structure and function along the dorsal-ventral axis despite being 
composed of similar elements.  This limb asymmetry is under the control of Lmx1b, a 
dorsalizing homeodomain-containing transcription factor.  Lmx1b knockout (KO) mice 
(Chen, et al., 1998) display distal ventral-ventral morphology in the bone, muscle and 
soft tissues.  In humans, single allele mutation of LMX1B causes Nail Patella Syndrome 
(NPS) (Dreyer et al., 1998) with incomplete dorsalization of extremities, i.e., loss of the 
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patella, deficient nails, and joint malformations.  However, limb-specific downstream 
target genes of Lmx1b have yet to be clearly defined. 
 The molecular control of dorsalization is initiated by Wnt7a expression in the 
limb bud ectoderm (Riddle, et al., 1995).  Progressive expression of the En-1 
transcription factor in the ventral ectoderm restricts Wnt7a to the dorsal ectoderm 
(Cygan, et al., 1997; Loomis, et al., 1998). Secretion of dorsally-restricted Wnt7a into the 
underlying mesoderm induces Lmx1b expression limited to the dorsal mesoderm (Vogel, 
et al., 1995).  During progressive joint and tendon formation (11.5dpc - 13.5dpc), the 
expression of Lmx1b proximally decreases and becomes restricted to differentiated 
tissues while retaining intense expression in the distal less-differentiated dorsal 
mesoderm (Dreyer et al., 2004).   
 The restriction of Lmx1b to dorsal tendons and joints during differentiation 
suggests a role in tendon/joint formation, but no direct link between Lmx1b and any 
tendon- or joint-related genes have been described.  In this report, we used microarray 
analysis to identify differentially expressed genes during joint, ligament and tendon 
formation in the presence (wildtype mice) or absence (Lmx1b KO mice) of Lmx1b.  
Progressive stages were analyzed and compared in an effort to minimize stage-specific 
differences and accentuate Lmx1b-specific targets.  Our analysis identified genes 
regulated by Lmx1b that are involved in asymmetric nerve, bone, joint, ligament, and 
tendon formation during dorsalization.  
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Materials and Methods 
Lmx1b KO Mouse 
 Lmx1b knockout (KO) mice were a kind gift of Randy L. Johnson (Chen, et al., 
1998).   Lmx1b homozygous mouse embryos were obtained by mating heterozygous male 
mice with heterozygous female mice.  We time-dated matings using noon on the day that 
the vaginal plug was found as 0.5 days post coitum (dpc).  At 11.5 and 12.5 dpc, embryos 
were harvested and the limb buds with the limb girdles were isolated.  Embryos at 
13.5dpc were also harvested and their distal limb buds (zeugopods and autopods) were 
isolated. Embryos were genotyped to confirm Lmx1b  homozygosity (-/- or +/+). 
 
Gene Expression Array 
 RNA from embryonic forelimbs and hindlimbs of wild type (WT) and Lmx1b KO 
mice was harvested using the Rneasy Kit (Qiagen).  RNA was pooled to decrease genetic 
variability, i.e., six limbs at 11.5 dpc, three limbs at 12.5 dpc and six limbs at 13.5 dpc.    
Duplicate samples were generated using different embryos for each stage and then 
hybridized to the Affymetrix GeneChip® Mouse Genome 430 2.0 Array (UCI, Irvine, 
CA).   Microarray data was submitted to Gene Expression Omnibus and can be located 
under series accession number GSE34732. The data was normalized using RMA and 
analyzed using the Comprehensive R and Bioconductor based web service for microarray 
data analysis (Rainer, Sanchez-Cabo, Stocker, Sturn, & Trajanoski, 2006). Genes 
differentially expressed between WT and Lmx1b KO mice with pvalue >0.05 were not 
considered significant and were not further analyzed. 
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 In order to enhance gene discovery, all genes with significant differential expression 
were examined to compare expression differences at all three stages. Genes which 
demonstrated a 2-fold change at any stage were considered for further analysis.  
 
Validation by Real-time PCR 
 Complementary DNA (cDNA) was transcribed from limb mRNA at each stage using 
both Lmx1b KO and WT mice. PCR products were sequenced to determine specificity 
(Supplemental Data Table 2). Differential expression was determined by Real-time PCR 
(Quantitative-PCR (Q-PCR)) measuring SYBR Green I fluorescence with the Roche 
Lightcycler 2.0 and Roche-recommended reagents. Triplicate Lightcycler runs with 
duplicate samples were compared to simultaneous PGK runs to normalize fold changes 
between Lmx1b KO and WT expression. Gene targets were considered validated if Q-
PCR data confirmed microarray data with at least a 2-fold change at any stage. 
 
Whole Mount in situ Hybridization 
 Sense and antisense digoxigen-labeled RNA probes ranging from 600bp – 1000bp 
were generated for each of the genes validated by Real-time PCR. Probes were sequenced 
to ensure specificity (Supplemental Data Table 2). Aggrecan probe sequence was 
generously provided by the Nancy Schwartz lab (Cortes, Baria, & Schwartz, 2009). 
Lmx1b KO and WT mouse embryos were harvested at 12.5 dpc and fixed overnight in 
MEMFA (0.1M MOPS, 2mM EGTA, 1mM MgSO4, 3.7% formaldehyde). Whole mount 
in situ hybridization was performed as described (Yamada, Szendro, Prokscha, Schwartz, 
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& Eichele, 1999) with each probe hybridized at 60°C, and embryos were washed post 
hybridization at 65°C. 
Results 
Determination of Candidate Genes by Comparative Microarray 
 In an effort to identify targets of Lmx1b involved in limb dorsalization, we isolated 
limb bud tissue with robust Lmx1b expression between 11.5 days post coitum (dpc) and 
13.5dpc. At 11.5 dpc, expression of Lmx1b is throughout the dorsal limb bud mesoderm 
(Fig 3.1B).  Thus, we harvested the entire limb bud as depicted in Fig 3.1A.   The tissue 
harvested includes presumptive limb girdle elements (e.g., scapula) and tissue that will 
become all three segments of the limb (stylopod, zeugopod and autopod).  Expression of 
Lmx1b at 12.5 dpc begins to localize to the condensing tendons proximally, while in 
distal less-differentiated dorsal mesenchyme, expression remains diffuse (Dreyer, et al., 
2004).  At this stage, we also harvested the entire limb including limb girdle elements 
(Fig.3.1A).  Lmx1b expression at 13.5 dpc wanes proximally but remains strong in the 
autopod (Fig.3.1B).  Therefore, the autopod was harvested at 13.5 dpc to coincide with 
strong Lmx1b expression (Fig.3.1A). In order to diminish biologic variability and 
enhance Lmx1b-associated changes, RNA was pooled from several different 
embryos/litters.  Genes with significant (p<0.05) differential expression were included in 
our data for this study. 
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Figure 3.1) Depiction of Methods  
A.) Depiction of the three developmental stages analyzed by microarray. Presumptive 
structures are color-coded at each embryonic stage depicting the progressive 
differentiation of the limb. Dashed red lines are drawn to illustrate the limb tissue 
harvested for gene array experiments. (dpc- days post coitum)  B) Section in situ 
hybridization for Lmx1b at 11.5 dpc (2) with expression pseudocolored red demonstrating 
restricted dorsal expression.  By 13.5 dpc (4), proximal expression of Lmx1b is less 
intense and localized to condensing musculo-tendonous tissue; distal Lmx1b expression 
remains diffuse in the dorsal mesoderm.  H&E of corresponding limbs show the amount 
of relative tissue differentiation at each stage(1,2). (musc- muscle) (cart- cartilage)  
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Figure 3.2) Analysis of Microarray Data 
A.) The number of genes with significant (p < 0.05) differential expression between WT 
and Lmx1b KO microarray analyses for each stage.  The last column identifies the subset 
of genes differentially expressed in all three stages.  B.) Graphical representation of 
ingenuity pathway assistant (IPA) analysis that identifies developmental processes and 
system networks containing the genes that are differentially expressed at each stage.  The 
relative significance determined by IPA defined parameters is listed on the y-axis. The 
number of genes in each network is listed at the top of each bar. The P value < 0.05 is 
denoted by the orange threshold line.  
 
 
 
 At 11.5 dpc, we identified 331 genes that were up-regulated in the presence of 
Lmx1b, while 368 genes were down-regulated.  Lmx1b up-regulated the expression of 
303 genes and down-regulated 1051 genes at 12.5 dpc.  By 13.5 dpc, Lmx1b up-regulated 
942 genes, and down-regulated 423 genes (Fig 3.2A).  
 To identify functionally relevant developmental pathways or networks used by 
Lmx1b, we analyzed our dataset with the Ingenuity Pathway Assistant (IPA) software 
(Fig 3.2B). When a comparison analysis is performed across stages, the data cluster into 
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several networks affected by Lmx1b. These include skeletal, connective tissue and 
nervous system developmental networks which correlate with morphology disrupted in 
the Lmx1b knockout (KO) mouse. Many of the targets discovered at individual stages 
may represent stage specific changes. In order to enrich genes downstream of Lmx1b 
during limb dorsalization, we identified genes with similar changes in expression for all 
three stages. We discovered 45 up-regulated genes and 9 down-regulated genes across all 
three stages. These genes were considered Lmx1b targets.  Similar studies by Kania et 
al., used a 1.4-fold change; we chose a more stringent criterion since we have a larger 
data set incorporating several embryonic stages. For further analysis, we required 
candidate genes to have at least a 2-fold change at one or more stages. In addition, we 
selected genes that we suspected to be involved with limb development pathways. Table 
1 lists the 23 genes which met this criterion, along with the fold change demonstrated at 
each stage.  
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Table 3.1)  Partial list of genes from microarray analysis regulated by Lmx1b 
during all three experimental stages 
A partial list of up and down-regulated genes identified by gene array across all three 
stages. Gene symbols and descriptions are listed along with the fold change at each stage. 
All data points listed in the table have a p value of < 0.05. Genes included in this partial 
list had a two fold change at one or more stages by gene array analysis. The final column 
indicates Q-PCR validation of this inclusion criteria.   
 
UP-REGULATED 
Description Symbol 11.5 FC 12.5 FC 13.5 FC Validated 
Empty spiracles homolog 2 
(Drosophila) Emx2 2.57 5.30 2.21 Yes 
Keratocan Kera 3.56 13.40 7.82 Yes 
Lumican Lum 2.56 3.67 2.33 Yes 
Decorin Dcn 1.43 2.10 2.57 Yes 
Aggrecan 1 Agc1 1.53 1.88 2.02 Yes 
Matrilin 1, cartilage matrix protein 
1 Matn1 2.09 3.07 2.36 Yes 
Matrilin 4 Matn4 1.41 1.60 2.03 Yes 
Growth differentiation factor 5 Gdf5 1.61 2.10 2.10 Yes 
Procollagen, type IX, alpha 3 Col9a3 1.51 1.53 2.07 No 
Procollagen, type XI, alpha 2 Col11a2 1.37 1.57 2.02 Yes 
Cerebellin 2 precursor protein Cbln2 1.54 2.45 2.21 Yes 
Lysyl oxidase Lox 1.59 2.45 1.45 Yes 
Epidermal growth factor-
containing fibulin-like 
extracellular matrix protein 1 Efemp1 1.46 1.68 2.37 No 
Noggin Nog 1.46 1.87 2.30 Yes 
Leukocyte cell derived chemotaxin 
1 Lect1 2.69 2.44 1.81 Yes 
Scinderin Scin 1.41 2.22 2.48 Yes 
Apolipoprotein D Apod 1.70 2.97 2.28 Yes 
Fam MGC99845 1.45 1.60 2.70 Yes 
Retinoic acid receptor, beta Rarb 1.51 2.04 1.45 No 
DOWN-REGULATED 
Regulatory factor X, 4  Rfx4 1.99 2.73 1.60 Yes 
RIKEN cDNA 1700109F18 gene Rik 1.31 2.49 2.09 No 
Myeloid ecotropic viral integration 
site 1 Meis1 1.31 1.41 2.24 No 
AF4/FMR2 family, member 3 Aff3 1.40 2.02 1.43 Yes 
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Validation of Candidate Lmx1b Target Genes by Real-time PCR 
 Candidate genes derived by microarray analysis were confirmed by Real-time 
PCR (Q-PCR) using SYBR green fluorescence.  Q-PCR data met the previously 
described 2-fold change criteria for 18 candidate genes (Fig 3.3). Four genes (denoted in 
red) fell below our threshold and were not examined further. The fold-change at 12.5 dpc 
was greater than at other stages for most of the Lmx1b related targets. This finding 
suggests that 12.5 dpc is a crucial time during dorsalization, with Lmx1b exerting its 
greatest influence on gene targets.  Thus, we examined the expression patterns of 
candidate genes in the WT and Lmx1b mutant mice at 12.5 dpc.  
 
 
 
Figure 3.3) Graphical representation of Real-time PCR (Q-PCR)  
 The fold change of each gene was measured at each stage; a 2-fold threshold is denoted 
by a blue line. Q-PCR validated microarray data for genes shown in black type. Genes 
denoted in red failed to meet validation criteria. The greatest fold changes are 
consistently seen at stage 12.5 dpc, therefore this stage was used for in situ hybridization 
analysis. * Col9a3 produced a 1.9-fold change at 12.5 dpc.  Since several other collagen 
related targets were also validated, Col9a3 was analyzed further.  
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Confirmation of Candidate Lmx1b Target Genes by Whole Mount in 
situ Hybridization (WMISH) 
 WMISH was utilized to determine differential expression for 19 genes.  Their 
expression patterns are briefly described below and illustrated in figures 3.4, 3.5, and 3.6, 
along with the expression pattern of Lmx1b (Fig 3.4 A,a, & A’,a’). 
 Apolipoprotein D (ApoD) is a carrier glycoprotein that is part of the lipocalin 
superfamily.  In humans, ApoD is a minor component of plasma high density 
lipoproteins. Apod has been reported as a potential downstream target of Lmx1b with 
dorsal ectodermal expression of ApoD demonstrated at 13.5 dpc (Gu & Kania, 2010). We 
found expression of ApoD proximally in the dorsal limb mesoderm (Figure 3.4 B,b, & 
B’,b’) and accentuated at the anterior presumptive wrist boundary in the presence of 
Lmx1b at 12.5 dpc (Fig. 3.4 B, white arrow). We also confirmed the previously reported 
expression within the dorsal ectoderm at 13.5 dpc (data not shown), indicating a stage-
specific shift in ApoD expression.  
 We found Empty spiracles 2 (Emx2), a transcription factor encoding gene linked 
to the formation of the scapula (a dorsal limb girdle structure), to be expressed diffusely 
within the dorsal limb girdle at 12.5 dpc (Fig 3.4 C,c).  Emx2 expression also extends 
from the limb girdle out into the dorsal autopod mesoderm.  In Lmx1b KO mice, 
expression of Emx2 is absent in both the scapular and dorsal limb mesoderm (Fig 3.4 
C’,c’). 
 Cerebellin 2 (Cbln2) is a cerebellum-specific, membrane-associated 
hexadecapeptide derived from Cerebellin 1.  Leukocyte cell-derived chemotaxin 1 (Lect1) 
is a cartilage-specific glycoprotein also known as Chondromodulin I. Interestingly in our 
WMISH Cbln2 and Lect1 both exhibit focal points of intense dorsal expression (Fig 3.4 
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D,d, D’,d’, E,e, & E’,e’). Cbln2 displays focal anterior and posterior limb girdle 
expression in the dorsal mesoderm (Fig 3.4 D white arrows). There is also concentrated 
expression overlying the proximal zeugopod (black arrowhead) and two discrete zones of 
dorsal expression at the zeugopod-autopod boundary (white arrowheads).  Lect1 has 
strong focal dorsal expression over the stylopod and a pattern similar to Cbln2 expression 
along the zeugopod-autopod boundary (Fig 3.4 E).  The limbs of Lmx1b KO mice show 
near absence of Cbln2 and Lect1 expression at all of these sites (Fig 3.4 D’d’ and E’,e’ 
respectively). 
 Several genes up-regulated by Lmx1b localize to the developing skeleton. Growth 
differentiation factor 5 (Gdf5) is a member of the TGF-beta superfamily of secreted 
growth factors. Gdf5 expression in WT limbs localizes to developing joints, interdigital 
regions and dorsal mesoderm along the zeugopod (Fig 3.4 F,f), and is prominent in the 
developing elbow joint (Fig 3.4 F, white arrow). In the Lmx1b KO mouse limb, Gdf5 
expression is absent from the area associated with the olecranon and reduced within 
interdigital regions (Fig 3.4 F’).  Matrilin 1 (Matn1) and Matrilin 4 (Matn4) are cartilage 
matrix proteins. Aggrecan (Agc) is a chondroitin sulfate proteoglycan, Agc, Matn1, and 
Matn4 expression surrounds condensing cartilage in the limb and the scapula at 12.5 dpc 
(Fig 3.4 G,g,H,h,I,i respectively).  Interestingly, the scapula lacks Agc, Matn1, and Matn4 
in Lmx1b KO mice (Fig 3.4 G’g’,H’,h’,I’,I’ respectively).   Agc and Matn1 is also absent 
in the ulnar anlagen, while Matn4 in the ulnar anlagen is absent distally. Additional 
skeleton-related genes identified by our gene array show symmetrical expression along 
the dorsal-ventral axis and include Noggin, Scinderin, Collagen9a3 and Collagen11a2. 
(Fig 3.5). These genes display decreased expression in Lmx1b KO mice.   
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 Lysyl oxidase 1 (Lox) encodes a connective tissue-related enzyme that is 
expressed strongly in the dorsal mesoderm from the limb girdle to the distal zeugopod 
(Fig 3.4 J,j). Lox in the Lmx1b KO mouse is greatly reduced (Fig 3.4 J’,j’). A cluster of 
connective tissue-related proteoglycans was also identified in our gene array as potential 
candidates: Keratocan (Kera), Lumican (Lum), and Decorin (Dec).  Kera is expressed 
intensely in the dorsal zeugopod mesoderm (Fig 3.4 K,k) and is undetectable in Lmx1b 
KO limbs (Fig 3.4 K’,k’).  Lum and Dec demonstrate strong dorsal mesodermal 
expression with very light staining of the proximal ventral mesoderm in WT limbs (Fig 
3.4 L,l,M,m).  Lmx1b KO limbs display greatly reduced dorsal expression of Lum and 
Dec; the residual staining is symmetrical and consistent with the light ventral expression 
seen in WT limbs (Fig 3.4 L’,l’,M’,m’). 
 The up-regulated target Family with sequence similarity 196, member B 
(Fam196b) is a predicted gene which was not detectable by WMISH.  
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Figure 3.4)  Whole Mount in situ Hybridization of Targets Up-regulated by Lmx1b  
WMISH for Q-PCR validated up-regulated genes at 12.5 dpc. Cartoon provides 
orientation for pictures, line along AP axis depicts cut performed for dorsoventral 
pictures. Dorsal views along with cross sections are shown for each gene. Expression 
patterns for each gene are as follows: Capital letter (e.g., A) denotes expression  in WT 
limbs along the dorsal surface, capital letter with apostrophe (e.g., A’) denotes expression 
in Lmx1b KO limbs along the dorsal surface. Small letter (e.g., a) marks WT limb 
sections while small letter with apostrophe (e.g., a’) indicates KO limb sections. B, white 
arrow indicates anterior Apod expression. D Cbln expression in the autopod (white 
arrowhead), zeugopod (black arrowhead), and  proximal/stylopod (white arrows). F, Gdf5 
in the olecranon (white arrow). H and I, black arrows both indicate scapular stain for 
Matn1 and Matn4, respectively.  
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Figure 3.5) Whole Mount in situ Hybridization of Skeletal Targets Up-regulated by 
Lmx1b 
Expression patterns for each skeletal related gene at 12.5 dpc are as follows. Capital letter 
(e.g., A) denotes WT expression along the dorsal surface. Capital letter with apostrophe 
(e.g., A’) denotes WT ventral expression while (A”) denotes cut sections. Small letter 
(e.g., a) marks WT limb sections while small letter with apostrophe (e.g., a’) indicates 
Lmx1b KO limb sections. All skeletal genes show a decrease in expression in the Lmx1b 
KO limb.  
 
 
 
 The two additional transcription factors that were identified by our gene array 
were down regulated.  Regulatory factor X,4 (Rfx4) is a winged helix transcription factor, 
which is expressed in the ventral limb mesoderm proximally and anteriorly (Fig 3.6 
A,A’,A’’white arrowheads ), and is duplicated in the dorsal mesoderm of the Lmx1b 
mutant (Fig 3.6 B,B’B’’white arrowheads). The nuclear transcription factor AF4/FMR2 
family, member 3 (Aff3) shows broad ventral expression within the presumptive soft 
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tissue of the zeugopod and autopod, surrounding the condensing cartilage and extending 
to the ectoderm, while on the dorsal aspect, the subectodermal expression is lacking (Fig 
3.6 C,C’,C’’,c’’red line).  Lmx1b KO limbs reveal broad symmetrical Aff3 expression 
patterns along the dorsal and ventral mesoderm (Fig 3.6 D,D’,D’’,d’’).  
 
 
 
 
Figure 3.6) Whole Mount in situ Hybridization of Targets Down-regulated by 
Lmx1b 
WMISH for Q-PCR validated down-regulated genes at 12.5 dpc, cut sections performed 
as illustrated by cartoon in Fig.4. Rfx4 is expressed dorsally (A) and ventrally (A’, white 
arrowhead; A”, cut section, white arrowhead) WT limb.  In the Lmx1b KO limb, Rfx4 is 
expressed dorsally (B) and ventrally (B’).  A cut section shows duplicated expression 
(B”, white arrowhead). C and C’ show dorsal and ventral Aff3 expression in WT limb, 
respectively. C” displays enhanced ventral Aff3 expression, magnification area denoted 
by the white box demonstrates absence of Aff3 in the dorsal subectodermal mesoderm 
(red line). D and D’ show dorsal and ventral expression of Aff3 in the Lmx1b KO limb, 
respectively. D” magnified in d’’, Aff3 is enhanced both dorsally and ventrally limb. 
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Discussion 
 
 Lmx1b is a homeodomain transcription factor known to be necessary and 
sufficient for dorsalizing distal limb structures including skeletal elements, nerves, 
tendons and ligaments. Loss of Lmx1b expression in Lmx1b KO mice causes scapular 
hypoplasia, distal ulnar hypoplasia, and loss of soft tissue dorsalization, i.e., symmetrical 
ventral-ventral or flexor-flexor ligaments, tendons and muscles (Chen & Johnson, 2002).  
Retroviral mediated overexpression of LMX1B in limb mesoderm generates a dorsal-
dorsal distal phenotype (Vogel, et al., 1995). Therefore, it is expected that Lmx1b 
regulates many diverse targets during limb dorsalization.  Supporting this concept, our 
microarray analysis revealed clusters of target genes associated with bone, connective 
tissue, and nerve development. 
 
Lmx1b Genes Associated With Skeletal Development 
 Our microarray data included several skeletal targets: Noggin, Growth 
differentiation factor 5 (Gdf5), Aggrecan (Agc), Scinderin, Collagen9a3, Collagen11a2, 
Matrilin1 (Matn1) and Matrilin4 (Matn4). Of these targets, Gdf5, Agc, Matn1 and Matn4 
demonstrate asymmetric expression in normal mice that is disrupted in Lmx1b KO mice 
(Fig 3.4 F’,G’,H’,I’). 
 Gdf5 is a regulator of joint and cartilage formation (Buxton, Edwards, Archer, & 
Francis-West, 2001). In the 12.5 dpc limb, Gdf5 is expressed within the developing joints 
and interdigital spaces (Fig 3.4 F). Notably, the developing elbow joint is an asymmetric 
structure with a prominent dorsal joint interface.  Correspondingly, Gdf5 expression 
includes a strip of dorsal mesoderm (Fig 3.4 F,white arrow).  In Lmx1b KO embryos, this 
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expression is absent, consistent with our microarray and Real-time PCR analysis.  In a 
previous report, no difference in Gdf5 expression was seen in autopod joints between 
normal and Lmx1b KO mice, however the elbow was not examined (Dreyer, et al., 2004).  
Although Lmx1b may regulate Gdf5 expression, Gdf5 KO mice do not present with 
obvious dorsoventral abnormalities; instead, loss of Gdf5 in mice and humans causes 
shortened limbs with abnormal joint formation and ossification of digits (Storm et al., 
1994).  Lmx1b plays a role in elbow development, since over 90% of patients with 
haploinsufficiency present with elbow dysplasia (E. M. Bongers, et al., 2002). Thus, the 
loss of Gdf5 expression in Lmx1b KO mice may signify a contribution to or reflection of 
deficient elbow dorsalization.   
 Agc is a highly expressed structural proteoglycan associated with cartilage 
development and maintenance. In the cartilage matrix deficiency mouse (CMD), wherein 
Agc is spontaneously/naturally deleted, there is marked limb hypoplasia with no apparent 
dorsal-ventral limb axis abnormalities (Watanabe & Yamada, 2002).  However, in our 
review of the published data, Agc deficient mice do appear to have more pronounced 
ulnar hypoplasia with ulnar deviation at the wrist.  Lmx1b KO mice show a loss of Agc 
expression within the presumptive ulna (Fig 3.4 G’). This deficiency in Agc expression in 
the posterior cartilage anlagen may contribute to the ulnar hypoplasia seen in the Lmx1b 
KO mouse.  
 Matrilin (Matn) genes exhibit overlapping expression patterns; in particular 
Matn1 and Matn4 are expressed in cartilaginous tissues where they bind collagen and 
proteoglycans to aid in skeletogenesis. Similar to Agc in the Lmx1b KO limb, Matn1 
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expression is lacking in the presumptive ulna (Fig 3.4 H’). In contrast, Matn4 expression 
is present within the proximal ulna anlagen, but is absent distally (Fig 3.4 I’).  
 Ulna formation is under the control of Sonic Hedgehog (Shh) (Ros et al., 2003). 
The differential expression patterns of Agc, Matn1 and Matn4 in response to Lmx1b 
suggest that posterior cartilage proteoglycan regulation may be a collective target of 
Lmx1b and Shh. Furthermore, these findings support the concept that Lmx1b may work 
in concert with other patterning factors along different axes, such as Shh, to generate 
asymmetrical structures. 
 
Lmx1b Regulated Genes Associated With Connective Tissue 
Development 
 A large second group of target genes uncovered by our analysis express within the 
dorsal limb mesoderm and, therefore, may be regulated by Lmx1b to pattern dorsal soft 
tissues.  These include: Empty spiracles homolog 2 (Emx2), Apolipoprotein D (ApoD), 
Lysyl oxidase (Lox), Keratocan (Kera), Lumican (Lum), and Decorin (Dec).  
 Emx2 expression extends along the dorsal mesoderm of the zeugopod, continuing 
distally into the autopod and digits (Fig 3.4 C). This expression is absent in Lmx1b KO 
limbs (Fig 3.4 C’). Overexpression of Emx2 in the chick model induced a single posterior 
or mirrored digit on the anterior border (Pröls et al., 2004).  A role for Lmx1b in the 
integration of Shh signals has been suggested by Tzchori and co-workers (Tzchori et al., 
2009), although no disruption of Shh signaling is evident in Lmx1b KO limbs (Chen, et 
al., 1998).  As suggested for posterior proteoglycans, it is possible that Lmx1b and Shh 
work in combination to also regulate digit-specific Emx2 activity.  Alternatively, Emx2 
60 
and Shh could work in concert to establish dorsal digit identity.  Irrespectively, 
overexpression of Emx2 in the limb appears to mimic or induce ectopic Shh expression.   
 ApoD is a multi-ligand, multi-functional transporter (Rassart et al., 2000).  The 
expression of ApoD at 13.5 dpc has been reported in the dorsal limb ectoderm (Gu & 
Kania, 2010).  We confirmed dorsal ectoderm expression at 13.5 dpc; however, at 12.5 
dpc, we found ApoD expression in the anterior dorsal mesoderm (Fig 3.4 B). With its 
stage-specific shift from dorsal limb mesoderm to ectoderm and loss of expression in 
Lmx1b KO limbs, it is unclear what role ApoD might play in limb development since 
ApoD KO mice have no reported limb abnormalities (Ganfornina et al., 2008).  
 Lox is a soft tissue associated target involved in collagen formation/maturation. 
Lox expression is broad in the proximal dorsal mesoderm extending out into the 
zeugopod (Fig 3.4 J). Lox expression at 12.5dpc overlaps Lmx1b expression in the 
zeugopod; however this expression is absent in the Lmx1b KO limb (Fig 3.4 J’). The role 
of this differential expression in response to Lmx1b is unclear.  Since Lox is a copper 
binding enzyme involved in crosslinking collagen and elastin (Kagan & Trackman, 
1991), it is possible that dorsal tendons/ligaments in mice have a composition of elastin 
and collagen that differs from ventral tendons and/or ligaments. 
 Kera, Dec, and Lum are proteoglycans associated with connective tissue 
development. Dec and Lum are associated with collagen fibrillogenesis and degeneration 
of the eye, skin and tendons. The ability to slow, but not to stop, the process of collagen 
formation allows for the homogeneous spacing between collagen fibrils during 
development. Not surprisingly, Dec KO (Danielson et al., 1997) and Lum KO mice 
(Chakravarti et al., 1998) present with irregularly spaced collagen, which causes weak or 
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abnormal connective tissue i.e. weak tendons with irregular attachment sites, and skin 
fragility.  Lmx1b KO mice display a marked reduction of Dec and Lum expression in the 
distal dorsal mesoderm with limited expression remaining in the proximal ventral and 
dorsal mesoderm (Fig 3.4 L,M). Kera has been studied in the embryonic eye and adult 
tendon where it is utilized for collagen fibril development and maintenance (Conrad & 
Conrad, 2003; Liu, Birk, Hassell, Kane, & Kao, 2003). Kera expression in the Lmx1b KO 
was undetectable (Fig 3.4 K’). In addition, expression of Collagen9a3 and Collagen11a2 
(Fig 3.5 C,D) is reduced in Lmx1b KO limbs(Fig 3.5 C’,D’).  The collective differential 
expressions suggest that Lmx1b plays an active role in collagen formation and 
maintenance, which may, in part, confer the dorsal character of these structures.  
 
Lmx1b Regulated Genes Associated With Neuronal Development and 
Angiogenesis 
  Cerebellin 2 (Cbln2) and Leukocyte cell-derived chemotaxin 1 (Lect) demonstrate 
a strikingly similar focal pattern of expression of the dorsal zeugopod and autopod (Fig 
3.4 D,E), which is greatly reduced in the Lmx1b KO (Fig 3.4 D’,E’).  Lmx1b guides the 
initial branching and subsequent trajectory of dorsal motor axons (Kania, Johnson, & 
Jessell, 2000). Interestingly, Cbln2 is abundant in the embryonic brain (Miura, Iijima, 
Yuzaki, & Watanabe, 2006) and has been linked to connectivity in sensory neurons 
(Reiner, Yang, Cagle, & Honig). Therefore, Lmx1b may work in conjunction with 
localized dorsal Cbln2 expression to guide motor axon trajectory and branching.  Lect 
functions as an inhibitor of angiogenesis in the growth plate (Shukunami, Iyama, Inoue, 
& Hiraki, 1999). Lect in the dorsal limb may assist Lmx1b in pattering blood vessels by 
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restricting vasculogenesis of targeted locations associated with innervation and joint 
formation.  
 
Lmx1b Regulated Genes Associated With the Developing Scapula 
 The scapula, a component of the limb girdle, also develops as a dorsal structure. 
Scapular development is a complex process. Signals from the lateral plate mesoderm 
pattern the head of the scapula while Hox genes from somites create a segmental pattern 
along the blade (Huang, Christ, & Patel, 2006; Huang, Zhi, Patel, Wilting, & Christ, 
2000).  Several knockout (KO) mouse models display varying degrees of scapular 
aplasia. Emx2 (Pellegrini, Pantano, Fumi, Lucchini, & Forabosco, 2001) and Wnt-
βcatenin (Hill, Taketo, Birchmeier, & Hartmann, 2006) KO mice display a complete loss 
of the scapula, while Pax1 KO mice develop hypoplastic scapulae lacking the acromion 
(Wallin et al., 1994).  Tbx15 KO mice develop a foramen in the blade (Singh et al., 
2005), Alx3 KO and Cart1 KOs (Brouwer, ten Berge, Wiegerinck, & Meijlink, 2003) 
reduce the rostral blade.  Despite these mechanistic insights, a comprehensive list of 
genes and how they interact during scapula formation remains unclear.  Expression of 
several genes discovered in our study localize to the developing scapula in normal mice. 
Other than Emx2, the targets identified in our analyses have not previously been 
associated with scapular formation.  Agc, Lum, Dec, and Lox show a reduction of 
scapular expression in Lmx1b KO mice (Fig 3.4 C’,G’,L’,M’).  Emx2, Matn1, and  Matn4 
exhibit a striking loss of scapular expression (Fig 3.4 H’,I’).  Since Lmx1b KO mice have 
hypoplastic scapulae, we suggest Lmx1b works in concert with these collective targets to 
augment scapular development.  
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Genes Down-Regulated by Lmx1b During Limb Development 
 We discovered two genes down-regulated by Lmx1b in the dorsal limb bud. 
Regulatory factor X, 4 (Rfx4) encodes for a transcription factor and has proximal anterior 
expression in the ventral mesoderm (Fig 3.6 A’).  This localized expression is duplicated 
in the Lmx1b KO limb (Fig 3.6 B’’). Rfx transcription factors have been associated with 
CNS development and may direct proximal nerve migration in the limb. A recent report 
found that an intraflagellar transport protein, ift172, is a target of Rfx4 regulation, and in 
a spontaneous mouse mutation, disrupted Shh and Gli signaling in the brain and spinal 
cord (Ashique et al., 2009).  Rfx4 expression was also observed in the limb, but no 
skeletal abnormalities were reported (Ashique, et al., 2009).  Soft tissue or nerve 
patterning, however, was not examined.  Thus, it is unclear what role this gene and the 
regulation of cilia may have on dorsal-ventral patterning.    
 AF4/FMR2 family, member 3 (Aff3) is expressed in both the dorsal and ventral 
mesoderm but has broader ventral expression during normal mouse limb development 
that includes the subectodermal mesoderm (Fig 3.6 C’’,c’’). In the Lmx1b KO mouse, 
Aff3 expression is equally accentuated in both the dorsal and ventral mesoderm (Fig 3.6 
D’’,d’’). Aff3 was initially discovered in association with lymphoid tissue (Ma & Staudt, 
1996), a more recent limb study detected expression at 11.5dpc and 13.5 dpc (Gyurján, 
Sonderegger, Naef, & Duboule, 2011). The presence of Aff3 within the developing limb 
and Q-PCR detected down-regulation by Lmx1b, suggests a role for Aff3 in dorsoventral 
patterning. 
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Summary 
 Previous studies have performed microarray analysis to discover downstream 
Lmx1b targets. Krawchuk and Kania (2008) used proximal WT and Lmx1b KO 11.5 dpc 
hindlimb tissue. Keratocan was the only target discovered coincident with our study; 
however, Keratocan was considered “not significant or inconclusive”. Our data and data 
from others (Randy Johnson, personal communication) find Keratocan significantly 
elevated in comparative WT and Lmx1b KO mouse limb gene arrays. We propose 
Keratocan is a significant Lmx1b target important to dorsal tendon formation. A second 
microarray analysis was also published using 13.5 dpc limbs (Gu & Kania, 2010; 
Krawchuk & Kania, 2008). This report revealed ApoD as a downstream target and Cbln2 
as a “target of interest”.  These two genes were also detected by our microarray study, 
supporting their role as Lmx1b targets.    
 The persistent asymmetrical elevation of a cluster of proteoglycans during limb 
dorsalization is a noteworthy discovery from our data and may provide clues to the 
mechanical mechanism of dorsal morphogenesis.  Kurpios and co-workers recently 
demonstrated differential proteoglycan content within left and right dorsal mesentery that 
caused asymmetric cell density, and the initiation of directional gut rotation (Kurpios et 
al., 2008).  Thus, one mechanism Lmx1b may use to orchestrate dorsalization is the 
regulation of proteoglycans that modulate cell shape, density and migration.   
 Our multi-stage microarray data expands previous investigations to include 
skeletal, connective tissue, neuronal, and angiogenic targets regulated by Lmx1b during 
limb dorsalization.  Several of these genes exhibit the Lmx1b binding site as described by 
Morello and coworkers (Morello, et al., 2001), suggesting direct Lmx1b regulation.  
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Although Lmx1b is necessary and sufficient to accomplish distal limb dorsalization 
(Chen, et al., 1998), many of the genes in our data sets demonstrate a  basal ventral 
expression. This finding supports the concept of Lmx1b functioning as a selector 
transcription factor in a multi-factor regulatory network as recently suggested by Qui and 
coworkers (Qiu, et al., 2009).   
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Table 3.2) Genes Common to all three arrays (11.5,12.5, and 13.5 dpc). Positive fold 
change values indicate genes up-regulated by Lmx1b, negative fold change denotes genes 
down-regulated by Lmx1b. Genes shaded in grey were also analyzed with whole mount 
in situ hybridization.  
 
Description Symbol GenBank 11.5 FC 12.5 FC 13.5 FC 
Predicted gene   AW493322 15.63 5.68 3.71 
Keratocan Kera 
NM_00843
8 3.56 13.40 7.82 
Empty spiracles 
homolog 2    
(Drosophila) Emx2 BG072869 2.57 5.30 2.21 
SLIT and NTRK-
like family, 
member 1 Slitrk1 AK014285 1.44 5.02 2.17 
Lumican Lum AK014312 2.56 3.67 2.33 
DEAD (Asp-Glu-
Ala-Asp)  Ddx3y AA210261 1.49 4.97 1.57 
Matrilin 1, 
cartilage matrix 
protein 1 Matn1 
NM_01076
9 2.09 3.07 2.36 
Apolipoprotein D Apod 
NM_00747
0 1.70 2.97 2.28 
Leukocyte cell 
derived 
chemotaxin 1 Lect1 
NM_01070
1 2.69 2.44 1.81 
Cerebellin 2 
precursor protein Cbln2 BQ175551 1.54 2.45 2.21 
Scinderin Scin 
NM_00913
2 1.41 2.22 2.48 
Neuronal growth 
regulator 1 Negr1 BM118381 2.10 2.22 1.79 
Decorin Dcn 
NM_00783
3 1.43 2.10 2.57 
Growth 
differentiation 
factor 5 Gdf5 
NM_00810
9 1.61 2.10 2.10 
  MGC99845 BB020678 1.45 1.60 2.70 
Noggin Nog 
NM_00871
1 1.46 1.87 2.30 
Epidermal growth 
factor Efemp1 BC023060 1.46 1.68 2.37 
74 
Lysyl oxidase Lox M65143 1.59 2.45 1.45 
Aggrecan 1 Agc1 
NM_00742
4 1.53 1.88 2.02 
Glycoprotein m6a Gpm6a BB348674 1.51 1.44 2.46 
Unc-5 homolog D 
(C. elegans) Unc5d BB525782 1.31 2.13 1.86 
Parathyroid 
hormone-like 
peptide Pthlh 
NM_00897
0 1.76 1.83 1.67 
RIKEN cDNA 
E330013P04 gene E330013P04Rik BG069958 1.74 1.76 1.75 
Pentraxin related 
gene Ptx3 
NM_00898
7 1.61 1.93 1.57 
proCollagen, type 
IX, alpha 3 Col9a3 BG074456 1.51 1.53 2.07 
Potassium 
voltage-gated 
channel Kcnab1 AK015412 1.31 2.16 1.62 
Matrilin 4 Matn4 
NM_01359
2 1.41 1.60 2.03 
3'-
Phosphoadenosin
e 5'-
phosphosulfate 
synthase 2 Papss2 BF780807 1.45 1.64 1.95 
Guanylate cyclase 
1, soluble, alpha 3 Gucy1a3 BG072799 1.79 1.57 1.66 
RIKEN cDNA 
C030026M15 
gene 
C030026M15Ri
k BB742957 1.31 2.31 1.38 
Retinoic acid 
receptor, beta Rarb BB266455 1.51 2.04 1.45 
RIKEN cDNA 
9430023B20 gene 9430023B20Rik BB021019 1.75 1.62 1.62 
proCollagen, type 
XI, alpha 2 Col11a2 AV242706 1.37 1.57 2.02 
cDNA sequence 
BC023892 BC023892 BE687858 1.34 1.90 1.70 
proCollagen, type 
XIV, alpha 1 Col14a1 AJ131395 1.44 1.94 1.47 
RIKEN cDNA 
5133401H06 gene 5133401H06Rik AK017223 1.47 1.47 1.85 
RIKEN cDNA 
3110032G18 gene 3110032G18Rik AK014112 1.45 1.57 1.69 
Dystrophin, 
muscular Dmd 
NM_00786
8 1.70 1.57 1.37 
75 
dystrophy 
Transmembrane 
and coiled coil    
domains 3 Tmcc3 BB711990 1.36 1.77 1.41 
proCollagen, type 
XI, alpha 1 Col11a1 
NM_00772
9 1.36 1.41 1.74 
Disabled homolog 
1 (Drosophila) Dab1 BB429377 1.36 1.43 1.66 
RIKEN cDNA 
3110032G18 gene 3110032G18Rik BB458543 1.32 1.48 1.64 
Cerebral 
endothelial cell 
adhesion   
molecule 1 Ceecam1 AV323203 1.38 1.38 1.64 
Tenascin C Tnc 
NM_01160
7 1.32 1.60 1.48 
Cadherin 10 Cdh10 AF183946 1.47 1.44 1.47 
            
            
Regulatory factor 
X, 4  Rfx4 AV255458 -1.99 -2.73 -1.60 
RIKEN cDNA 
1700109F18 gene Rik BB421876 -1.31 -2.49 -2.09 
Myeloid ecotropic 
viral integration 
site 1 Meis1 BB055155 -1.31 -1.41 -2.24 
AF4/FMR2 
family, member 3 Aff3 BM239026 -1.40 -2.02 -1.43 
BG068672 
(GenBank)   BG068672 -1.52 -1.77 -1.52 
Corticotropin 
releasing 
hormone binding 
protein Crhbp AI854101 -1.36 -1.40 -1.83 
Fusion derived 
malignant 
liposarcoma  Fus BE985138 -1.59 -1.48 -1.46 
Myeloid ecotropic 
viral integration 
site-related gene 1 Mrg1 BM124348 -1.34 -1.44 -1.73 
Odd Oz/ten-m 
homolog 4 
(Drosophila) Odz4 BB046190 -1.37 -1.38 -1.42 
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Table 3.3) Primer Sequences for qPCR and WMISH Probe Generation, primers are listed 
in the 5’ to 3’ orientation.  
 
Primer sequences 
Gene 
Description 
GenBank qPCR 5p 
primer 
qPCR 3p 
primer 
Probe 5p 
primer 
Probe 3p 
primer 
Keratocan NM_008438 GTGATTC
CTAAGGT
GGCTTTCC
CTTCATTC
ACGGACCA
CAAC 
GAGAAGC
CCTTTGAG
AATGC 
CTTCATTC
ACGGACC
ACAAC 
Leukocyte cell 
derived 
chemotaxin 1 
NM_010701 CCAATGT
TCAGGAC
GACG 
CCTAGACT
GGACCATG
AAGG 
CAATGGA
AATAGAT
GCTGTGAA
C 
CCTAGACT
GGACCAT
GAAGG 
Empty spiracles 
homolog 2 
(Drosophila) 
BG072869 GAGAGTT
TCCTTTTG
CACAACG 
GCTAGAGC
ACGCTTTT
GAG 
CTCGGCGC
AGCATGTT
TCAG 
GGTGGAG
AATTGCTA
CCAAGC 
Lumican AK014312 CTTCACTG
GGCTGCA
ATACC 
GGACCACT
GTCTTACT
CCAAG 
CAATGAA
CTGGCTGA
TAGTGG 
CATGTCA
AGTCTGTT
TTGC 
Matrilin 1, 
cartilage matrix 
protein 1 
NM_010769 CTGTGCCT
GTGAGTC
CATAC 
CTAAGAAC
TCTGGTGG
CCTG 
CTGTGCCT
GTGAGTCC
ATAC 
CCAGTTA
ATTCTTTA
CCCAGTC
AG 
Apolipoprotein 
D 
NM_007470 GTGCAAG
AGAATTT
TGACG 
GAAAGGA
AACTGCAT
TCAAGC 
GTGCAAG
AGAATTTT
GACG 
CCACACT
GTCACCTT
GCTAG 
Growth 
differentiation 
factor 5 
NM_008109 GTAACAG
CAGCGTG
AAGTTGG 
GTTTGACA
TCAGTGCC
TTGG 
GTAACAG
CAGCGTG
AAGTTGG 
GCAGTCA
TTCAGACC
CTAATG 
Lysyl oxidase M65143 CCAGAAG
ATGTCTAT
GTACAAC
C 
GGTACTGC
TACGATTT
CC 
CCTACTAC
ATCCAGGC
TTCC 
GCAACAA
ATGACAT
AACTG 
Cerebellin 2 
precursor protein 
BQ175551 GATGAGC
AACCGTA
CCATGAC 
GGTCAAAG
TGTACAAC
AGACAAA
C 
GATGAGC
AACCGTAC
CATGAC 
CCTGTGTT
CTGTGTGT
GTGTAG 
Aggrecan 1 NM_007424 ATCGCTA
CGAGATC
AGCTCC 
CCAACACC
TACAAGCA
CAG 
GAATTGG
ACAGTAGT
GC 
GACGGAA
CTGTCTGG
CACATC 
Retinoic acid 
receptor, beta 
BB266455 CAGAAGT
GCTTTGA
AGTGG 
GAATGCAC
AGAGAGCT
ATGAG 
Did not meet 
criteria to 
continue 
Did not meet 
criteria to 
continue 
Procollagen, 
type IX, alpha 3 
BG074456 CTGAAGG
TGCTACT
GTTGGCAA
AGATGGTG
CTGGACCT
CCTGGAA
CCTGGAG
ATGTTGGT
77 
GATCTGC AG ACC GTTC 
Epidermal 
growth factor-
containing 
fibulin-like 
extracellular 
matrix protein 1 
BC023060 CACCTGG
TTCCTTCT
ACTGC 
CAGTGTGC
TCAACAAT
GC 
Did not meet 
criteria to 
continue 
Did not meet 
criteria to 
continue 
Noggin NM_008711 CTGAGCA
AGAAGCT
GAGG 
CCATCCAA
GTCTGTGC
AC 
CTGAGCA
AGAAGCT
GAGG 
CCTGCTAT
TTATATCC
CAGTAC 
Predicted 
gene/MGC99845
/Fam196b 
BB020678 GGAACTT
CTATCGG
ACTGG 
GTTCCATG
AGGTTCTC
CAG 
Could not 
detect with 
WMISH 
Could not 
detect with 
WMISH 
Decorin NM_007833 GGAAATC
CGACTTC
AATGG 
CCAACATA
ACTGCGAT
CCCTC 
CTCTCATC
TTCTTCCT
TCTGG 
CCAACAT
AACTGCG
ATCCCTC 
Matrilin 4 NM_013592 GATCTCA
TCCAGGA
GTTTGG 
GCAACTCT
GGCTACAA
GCTAG 
GCTATAAT
GGGCCCCT
GGATTTGG
GCAACTCT
GGCTACA
AGCTAG 
Scinderin NM_009132 GAGTCGA
CTGATTTT
GTGG 
CGAAAAG
ACTTCTGC
ACG 
CGTGTAGA
GAACAGT
GGTAGAG 
CCTCTGAG
GAAGTAA
TTTTGTC 
Procollagen, 
type XI, alpha 2 
AV242706 CAAGGCT
GGACGAA
GG 
GGAGAAC
CTGGCATG
AAG 
CACTGAA
AGCTGCTG
ACATC 
GGAACCA
GCAAGAC
TTCATAAG
RIKEN cDNA 
1700109F18 
gene 
BB421876 GGATCGG
GTAGGAA
GCTC 
CTGCTGGA
GTGTGAGA
GG 
Did not meet 
criteria to 
continue 
Did not meet 
criteria to 
continue 
Myeloid 
ecotropic viral 
integration site-
related gene 1 
BG073335 GTGCAGC
CCATGAT
AGACC 
GGTTTTGT
AATGGACG
GTC 
Did not meet 
criteria to 
continue 
Did not meet 
criteria to 
continue 
AF4/FMR2 
family, member 
3 
BM239026 CAGCCAG
TCATGCA
TTAGAC 
CGACAACG
AAGATGAC
TACAG 
CTGATTCT
TGCTCGTC
ACAC 
GGACCAG
AACTGTTT
TTATAAG 
Regulatory 
factor X, 4 
(influences HLA 
class II 
expression) 
AV255458 AGACCGA
TGCGTTGT
AAAG 
GACATGAC
CTTGCACA
GTG 
CAGCTAAC
CACCAGA
AGACTC 
GACATGA
CCTTGCAC
AGTG 
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Abstract 
 
Many of the molecular pathways used to pattern the developing limb are 
conserved across divergent species. The limb develops along three axis; proximal-distal, 
anterior-posterior, and dorsal-ventral. The molecular pathway by which dorsoventral limb 
patterning occurs is incompletely characterized.  Lmx1b, a LIM homeodomain 
transcription factor is necessary and sufficient for limb dorsalization; however, 
downstream targets of Lmx1b are unknown.  Identification of these downstream targets is 
essential for understanding patterning of the dorsal-ventral limb axis. Previous studies 
have identified several proteoglycans as potential downstream gene targets of Lmx1b. In 
12.5 dpc mouse limbs, Keratocan, Lumican, and Decorin, were dorsally restricted, while 
Aggrecan was not. We hypothesized the expression of these target genes would be 
conserved across tetrapods. To test this hypothesis, we examined the expression of these 
proteoglycans in both mouse and chick embryonic forelimbs and hindlimbs at 
corresponding stages.  (11.5 -14.5 dpc and Hamburger-Hamilton stages 22 - 29, 
respectively) by whole mount in situ hybridization. The expression of Aggrecan was 
highly conserved, localizing to condensing cartilage during the stages examined in both 
mouse and chick fore/hindlimbs. In contrast the expression patterns of Keratocan, 
Lumican, and Decorin was not conserved between chick and mouse. In mouse, all three 
proteoglycans were initially (11.5 dpc) expressed within the dorsal mesoderm. By E14.5 
Keratocan localized to the dorsal and ventral tendons, whereas Lumican and Decorin 
retained dorsal expression with additional focal proximal expression within ventral 
mesoderm of the hindlimb.  In the chick, Keratocan and Decorin expression was initiated 
in both dorsally and ventrally mesoderm progressively localizing to ventral and dorsal 
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tendons. Lumican is expressed in the superficial dorsal and ventral mesoderm including 
the sub-AER region. Lumican also develops diffuse dorsal and ventral mesodermal 
expression in the hindlimb, beginning at HH25. The marked difference in expression 
between mice and chicks during limb dorsalization was unexpected.  These contrasting 
expression patterns suggest that the Lmx1b-directed cascade of gene regulation during 
limb dorsalization is not conserved across species.  The disparity may also reflect 
species-specific variations in dorsal limb evolution, structure, and function.   
 
Introduction 
Despite a variety of adult limb conformations, early vertebrate limb 
morphogenesis is remarkably similar across divergent species. From fish to humans, this 
observation was aptly recognized and described by 19th century embryologists such as 
Karl Ernst von Baer in 1828 (Russell, 1917).  Early limb development begins as a bud of 
tissue emerging from the lateral plate mesoderm.  Asymmetric development advances 
along three coordinate axes, proximal-distal, anterior-posterior, and dorsal-ventral.  
In addition, to morphology, the molecular pathways that orchestrate limb 
development are largely retained. Development along the proximal-distal axis, utilizes 
the apical ectodermal ridge (AER), a thickened ridge of distal ectoderm. Fibroblast 
growth factors secreted from the AER stimulate growth in the underlying undifferentiated 
mesoderm and progressively distalizes the limb during outgrowth. This epithelial-
mesenchymal interaction is conserved across vertebrate species, retaining the critical 
molecules in the pathway with some minor species-specific variations (Mercader, 2007).  
For example, in zebrafish Tbx5 in the presumptive fin mesoderm induces Fgf10 secretion 
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which up-regulates Fgf24, Fgf16, and Fgf8 in the AER through a Wnt intermediate.  
Similarly in mice, Tbx5 in the presumptive limb mesoderm up-regulates Fgf10, which in 
turn induces Fgf8, Fgf4, Fgf9 and Fgf17 in the AER via intermediary Wnt genes.  Thus, 
the molecular pathway and downstream targets are conserved even though different 
species use distinctive Fgfs to accomplish limb outgrowth.  
A cluster of cells known as the zone of polarizing activity (ZPA) directs 
development along the anterior-posterior axis.  The ZPA secrets sonic hedgehog (Shh) 
inducing proliferative limb bud expansion and distal anterior-posterior patterning.  The 
Shh pathway is also preserved in vertebrate appendages from fins (Dahn, Davis, 
Pappano, & Shubin, 2006) to tetrapod limbs (Mercader, 2007). 
The dorsal ectoderm polarizes the dorsal-ventral axis.  Initially, Wnt7a is 
expressed in the ectoderm overlying the presumptive limb.  En-1 is up-regulated in the 
ventral ectoderm as the limb bud emerges and limits Wnt7a expression to the dorsal 
ectoderm (Cygan, et al., 1997). Wnt7a induces the LIM-homeodomain transcription 
factor Lmx1b, in the underlying mesoderm (Vogel, et al., 1995) and Lmx1b is 
responsible for limb dorsalization (Chen, et al., 1998; Riddle, et al., 1995; Vogel, et al., 
1995).  The molecular mechanisms initiating dorsal-ventral axis formation in the limb are 
also conserved across vertebrates (Mercader, 2007).  
We wondered whether conservation of the molecular dorsal-ventral pathway in 
the limb extended to downstream targets, however, the molecular cascade beyond Lmx1b 
is not well characterized.  Several microarray studies have been performed to identify 
limb related downstream Lmx1b targets (Feenstra et al., 2012; Gu & Kania, 2010; 
Krawchuk & Kania, 2008); all of these studies have discovered one or more proteoglycan 
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genes up-regulated by Lmx1b during limb dorsalization. Proteoglycans are extracellular 
matrix molecules that have been implicated in several developmental processes including 
CNS development (Bandtlow & Zimmermann, 2000) and skeletal formation 
(Waddington, Roberts, Sugars, & Schonherr, 2003).  
In this report we examined the expression of proteoglycans discovered by 
differential gene array analysis during limb dorsal-ventral axis formation in the mouse; 
Keratocan, Lumican, Decorin, and Aggrecan. We further examined the expression in 
chickens during limb development to determine whether the dorsal-ventral molecular 
cascade was conserved.  Mouse cells located in the dorsal limb mesoderm do not cross or 
migrate to the ventral compartment after 10.5 days post coitum (dpc) (Arques, et al., 
2007; Pearse, et al., 2007; Qiu, et al., 2009), creating a distinct dorsal-ventral boundary 
which may be the first step in limb dorsalization.   Therefore, we examined expression of 
proteoglycans beginning with compartment restriction (11.5 dpc and HH23) and ending 
with differentiation of skeletal elements when Lmx1b expression decreases.  Despite the 
similarity of vertebrate limbs, chicks have a more derived forelimb with only three digits, 
whereas the hindlimb has four digits and more closely parallels rodent limbs. Thus, to 
compare target genes of the Lmx1b dorsalization pathway, we examined expression 
patterns in both the forelimb and hindlimb of mice and chickens. When comparing mouse 
and chick, we discovered an early disparate expression pattern for Keratocan, Lumican 
and, Decorin that terminally converged within tendons.  
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Materials and Methods 
Brown Leghorn eggs were incubated at 39oC until Hamburger-Hamilton (HH) 
(Hamburger & Hamilton, 1951) stages 22-29.  CB57/bl mouse embryos were harvested at 
stages 11.5, 12.5, 13.5 and 14.5 days post coitum. Embryos were harvested and fixed 
overnight in MEMFA (0.1M MOPS, 2mM EGTA, 1mM MgSO4, 3.7% formaldehyde).  
Digoxigenin labeled probes were used to detect Lmx1b, Keratocan, Lumican, Decorin, 
and Aggrecan. Table 1 contains previously unpublished chick probe sequences, mouse 
probe sequences were previously described (Feenstra, et al., 2012). Mouse and chick 
Aggrecan probe sequences were derived from plasmids which were a kind gift of the 
Nancy Schwartz lab (Cortes, et al., 2009).   WMISH was performed as previously 
described (Yamada et al., 1999) with each probe hybridized at 60oC and embryos washed 
post hybridization at 65oC. 
Results and Discussion 
 
Lmx1b 
 
As previously reported (Dreyer, et al., 2004; Vogel, et al., 1995), Lmx1b 
expression is evident throughout the dorsal mesoderm of the mouse 11.5/12.5 dpc and 
chick HH23/25 limb (Fig 4.1). Subsequent expression of mouse (13.5/14.5 dpc) and 
chick (HH 27/29) limbs is reduced in the proximal region but remains strong distally. 
Hindlimb expression is slightly delayed in both. Later stages of the mouse (13.5/14.5 
dpc) display enhanced expression in the joints of the autopod.  The expression and 
function (Chen, et al., 1998; Vogel, et al., 1995) of Lmx1b is similar in mouse and 
chicks, supporting the concept that Lmx1b is conserved across species as a mediator of 
limb dorsalization.  
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Figure 4.1) Lmx1b Expression Pattern Comparison 
In the chick and mouse Lmx1b localizes to the dorsal limb mesoderm during limb 
development. Cartoons illustrate orientation of images, dorsal limb surface and a cut 
section to visualize the dorsal/ventral limb compartments. Line through the dorsal limb 
view (anterior/posterior) depicts where D/V cuts were made. Lmx1b expression is 
conserved between forelimb and hindlimb of the chick and mouse. 
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Aggrecan 
 
In mice, Aggrecan (Acan) expression localizes to condensing limb cartilage with 
progressive development (Fig 4.2).  Similarly, chick Aggrecan (ACAN) expression is 
apparent by HH25 and highlights the condensing cartilage of the stylopod, zeugopod, and 
distal posterior autopod.  With stage progression, Aggrecan accentuates the developing 
digits in a posterior to anterior pattern. By HH29, intense ACAN expression delineates the 
majority of the limb skeleton.  Thus, in both mice and chicks, Acan expression denotes 
where cartilage condensations will form during limb skeletogenesis. 
Aggrecan is an important component of the cartilage extracellular matrix, where it 
forms charged aggregates within the collagen network. These charged aggregations alter 
water content and binding thereby providing cartilage elasticity and compression 
resistance.  Loss of Acan function in the chick and mouse causes severe dwarfism (H. Li, 
Schwartz, & Vertel, 1993; Watanabe et al., 1994). Similarly in humans, a homozygous 
partial truncation of Acan causes severe dwarfism (Tompson et al., 2009).  Our data 
further supports the notion that Acan is conserved across divergent species as a molecular 
component important for chondrogenesis.   
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Figure 4.2) Aggrecan Expression Pattern Comparison 
Aggrecan localizes to condensing cartilage of the chick (HH25/27/29) and mouse 
limb(12.5/13.5/14.5 dpc). A dorsal view of the limb is shown along with a cut section to 
illustrate dorsal/ventral expression differences. Aggrecan is expressed in the digits in a 
posterior to anterior pattern best visualized in the chick (HH27).  
 
 
 
 
Keratocan and Decorin 
 
Keratocan, Decorin and Lumican are small leucine rich proteoglycans (SLRP) 
that are important for directing collagen fibril assembly during development. These three 
SLRP’s are genomically clustered together, which may suggest coordinated or possibly 
redundant function.  Furthermore, Keratocan (Fig 4.3) and Decorin (Fig 4.4) have a 
similar expression pattern that localizes to developing tendons at HH29 and 14.5 dpc.  
Keratocan expression in the mouse limb is first evident as a small region in the 
proximal dorsal mesoderm at 11.5 dpc.  With development, expression spreads distally to 
involve the midline of the dorsal zeugopod and extends to the autopod but is absent from 
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the distal digits.  By 14.5 dpc, Keratocan localizes to the dorsal tendons and a few ventral 
tendons of the murine limbs (Fig 4.3D, arrows).  
In contrast, Keratocan within chicken limbs originates superficially in the distal 
dorsal and ventral mesoderm at HH23 (Fig 4.3A).  Keratocan expression continues in the 
developing autopod region through HH25 (Fig 4.3B). By HH27 Keratocan expression 
has expanded proximally into dorsal and ventral zeugopod mesoderm with waning 
expression within the autopod and posterior clearing that excludes the region of the ZPA 
(Fig 4.3C). With further development (HH29), Keratocan expression localizes to forming 
dorsal and ventral tendons (Fig 4.3D). 
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Figure 4.3) Keratocan Expression Pattern Comparison 
In the mouse Keratocan displays dorsally restricted proximal expression, which later 
localizes to tendons, arrows indicate ventral tendons. In the chick Keratocan displays 
distal mesodermal expression, which localizes to dorsal and ventral tendons. Dorsal, 
ventral and dorsal/ventral (DV) cut sections are shown; ventral images are flipped 
horizontally to facilitate expression pattern comparison. 
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Similar to Keratocan, Decorin is first expressed in the proximal dorsal aspect of 
murine limbs.  At 11.5 dpc, Decorin is expressed in the forelimb as a small proximal 
region of dorsal mesoderm at the midline, while in the hindlimb Decorin expression 
localizes to the proximal posterior aspect of the dorsal mesoderm (Fig 4.4A). Decorin 
expression at 12.5 dpc broadens anteriorly within the dorsal mesoderm and also appears 
proximally within the ventral mesoderm (Fig 4.4B). In the forelimb and the hindlimb at 
13.5 dpc Decorin expression extends toward the autopod to lie directly below carpals (Fig 
4.4C). At 14.5 dpc Decorin expression remains intense within the dorsal zeugopod with 
expanded expression ventrally, condensing into presumptive dorsal and ventral 
myotendinous bundles (Fig 4.4D).  
Within the chicken limb at HH23, Decorin expression, like Keratocan, begins 
distally within the central superficial dorsal and ventral mesoderm (Fig 4.4A). With 
continued limb outgrowth (HH25-HH27), Decorin expression extends proximally to 
include the zeugopod and autopod (Fig 4.4B). By HH29, Decorin expression within the 
autopod clears except for limited dorsal and ventral tendon expression; however, Decorin 
expression within the zeugopod mesoderm remains strong while highlighting condensing 
tendons. 
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Figure 4.4) Decorin Expression Pattern Comparison 
Decorin displays dorsally restricted expression in the mouse beginning proximally, by 
14.5dpc Decorin condenses to tendinous bundles (white arrow). In the chick Decorin 
begins distally and localizes to dorsal and ventral tendons.  
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Thus, in both mouse and chick limbs, Keratocan and Decorin localize to 
developing tendons in due course.  This localization suggests a role in tendon formation 
or maturation. Supporting this concept, Keratocan and Decorin expression overlaps 
Scleraxis, a marker of tendon progenitors, in the superficial mesoderm (Schweitzer et al., 
2001). Although little is known regarding the function of Keratocan in tendons, abnormal 
corneal collagen fibril formation has been reported with loss of functional Keratocan in 
humans and mice (Khan & Kambouris, 2004; Liu, et al., 2003). Decorin is thought to 
control the rate of collagen fibril assembly (Zhang et al., 2006) and Decorin KO mice 
display disrupted collagen fiber formation and skin fragility (Danielson, et al., 1997). 
Together these findings suggest Keratocan and Decorin have a complementary role in 
patterning the collagen composition of limb tendons. 
However, there is a striking species-specific difference in the initial and evolving 
expression patterns during limb development.  In the mouse, expression begins 
proximally and extends distally, while in the chick, expression begins distally and 
extends proximally. These disparate patterns of proteoglycan expression may indicate 
different mechanism of regulation to attain the same eventual localization.  Alternatively, 
this species-specific discrepancy could indicate a fundamental difference in how mouse 
and chick tendons develop.  
 
Lumican 
 
In the mouse, Lumican expression is present at 11.5 dpc within the proximal 
dorsal mesoderm (Fig 4.5A) and subsequently expands distally across the zeugopod by 
12.5 dpc (Fig 4.5B) similar to Keratocan and Decorin. Weak ventral staining is also 
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present proximally, at 12.5 dpc and increases in intensity through 14.5 dpc (Fig 4.5D). 
Dorsal expression expands to include the majority of dorsal mesoderm by 13.5 dpc, 
excluding the distal autopod.  By 14.5 dpc, Lumican expression extends to the distal 
autopod accentuating dorsal and ventral digital tendons (Fig 4.5D).  
Similar to Keratocan and Decorin, Lumican expression in chick limbs at HH23 
involves the central dorsal and ventral mesoderm at the distal tip (Fig 4.5A).  The 
expression extends along the anterior peripheral aspect of the limb.  In addition, Lumican 
expression is present within the zone of polarizing activity (ZPA).  Thus, a band of 
Lumican negative distal mesoderm separates the anterior and ZPA related areas of 
expression that involve both dorsal and ventral mesoderm.  The pattern persists through 
HH25 with increasing expression intensity (Fig 4.5A/B). By HH25, weak Lumican 
expression is also evident superficially in the zeugopod mesoderm.  The anterior and 
ZPA related expressions coalesce at HH27 generating a definitive sub-apical ectodermal 
ridge (AER) band of expression (Fig 4.5B/C). With further development (HH29) the 
superficial central limb expression in the forelimb becomes more restricted.  
Concurrently, there is an overall decrease in forelimb expression including the autopod, 
which highlights the sub-AER staining (Fig 4.5D). The hindlimb at this stage (HH29) 
retains sub AER staining but also displays diffuse mesodermal staining of the zeugopod 
and stylopod.  
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Figure 4.5) Lumican Expression Pattern Comparison 
Lumican displays dorsally restricted expression in the mouse and an interesting sub AER 
pattern in the chick limb.  
 
 
The unique sub-AER pattern of Lumican expression in chickens is similar to the 
pattern of downstream Fibroblast Growth Factor target genes such as DUSP6 (C. Li, 
Scott, Hatch, Tian, & Mansour, 2007) and TFAP2C (unpublished data).  In the mouse 
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there are no detectable levels of Lumican expression in the same sub-AER region. This 
species specific difference in induction suggests that Lumican is regulated by AER 
related factors such as FGF in the chick and a different molecular network in the mouse.  
 
 
Conclusion 
 
In this report we examined the expression of proteoglycans that are associated 
with chondrogenesis and collagen formation during limb development in mice and 
chickens.  In mice, these proteoglycans are elevated in the presence of Lmx1b and 
accentuated dorsally during limb development (Feenstra, et al., 2012).  We confirmed 
similar expression of Lmx1b expression within the dorsal mesoderm of mouse and 
chicken limbs during the stages examined.  We also found similar mouse and chick 
expression patterns for Aggrecan, a potential downstream target of Lmx1b.  
However, the expression patterns of Keratocan, Decorin and Lumican were 
remarkably different in mice and chickens.  In mice, the expression is first evident 
proximally in the dorsal mesoderm and progresses distally with limb outgrowth.  In 
contrast, these proteoglycans are initially expressed distally in chick limbs and expand 
proximally.  Furthermore, Lumican displays an additional sub-AER expression in chicks 
that is not present in mice.   The initiation of expression in opposing limb regions 
followed by a convergence of expression and the unique sub-AER Lumican expression 
are interesting and unexpected differences  between these species.   
Although the expression of Lmx1b within dorsal limb mesoderm mediates limb 
dorsalization across vertebrate species (Mercader, 2007), our disparate patterns of 
proteoglycan expression suggest that the Lmx1b-directed cascade of gene regulation 
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during limb dorsalization is not conserved across species.  The disparity may also reflect 
species-specific variations in dorsal limb evolution, structure, and function. Additional 
studies will be needed to clarify the role of these proteoglycans in limb development. 
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Abstract 
Lmx1b, a LIM homeodomain transcription factor, is necessary for limb, kidney, 
eye, and central nervous system development. Lmx1b knockout (KO) mice display 
reduced cerebellar and tectal formation, loss of dopaminergic/serotonergic neurons, 
ocular malformations, and ventral–ventral limb symmetry. The mechanism by which 
Lmx1b patterns so many diverse tissues remains unclear. Recent microarray studies in 
the limb have revealed multiple extracellular matrix molecules as possible downstream 
Lmx1b targets. In particular, the proteoglycans Keratocan, Lumican, and Decorin 
demonstrate a striking loss of expression in the Lmx1b KO mouse.  Interestingly, these 
proteoglycans cluster together at one genomic locus (KLD) and 5’ to this KLD locus is a 
900 kilobase region devoid of coding sequences, i.e., a gene desert.  Using in silico 
analysis we identified 12 conserved noncoding regions (CNRs) surrounding the KLD 
locus and within the gene desert.  Two of these CNR’s, Peak 3 and Peak 10, contain a 
known Lmx1b binding site (TAATTA or “FLAT” site). We hypothesize that Lmx1b 
directly regulates KLD via CNR Peak 3 and Peak 10. We isolated the CNR regions 
and linked them to a green fluorescent protein (GFP) reporter plasmid. These constructs 
were electroporated into chick embryos at the primitive streak stage (Hamburger-
Hamilton (HH) 4), during early neural tube formation (HH10), and during early limb 
formation (HH14). GFP expression, and thus enhancer activity, was detected for Peak 3 
in the neural tube beginning at HH10. As development progresses Peak 3 activity appears 
within the developing midbrain and cerebellum. At HH19, LMX1B and KLD mRNA 
expression overlap the region of Peak 3 enhancer activity. Additionally electroporation of 
a 40 base pair fragment, which contains the FLAT site and several potential surrounding 
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binding sites,displays localized activity similar to the complete Peak 3. This data 
indicates that this 40 base pair sequence containing an Lmx1b binding site is sufficient to 
produce Peak 3 activity. Our data further suggests that Lmx1b may regulate CNS 
morphogenesis by altering the extracellular matrix composition such as KLD 
proteoglycans.  Furthermore, the activity of the minimal KLD-associated Peak 3 FLAT 
site localized to Lmx1b-dependant CNS structures during development supports a direct 
role for Lmx1b regulation. 
 
 
Introduction 
 
The establishment of techniques and software programs capable of genomic 
alignment and analytical bioinformatics has allowed researchers to compare diverse 
vertebrate genome sequences. Specifically, these methods can be used to detect cis-
regulatory regions found in the noncoding areas of nearby gene targets. Cis-regulatory 
regions are thought to contain target sites for transcription factors thereby enhancing or 
silencing nearby gene function. Since it is likely that evolutionary conservation of cis-
regulatory sequences occurs by fitness selection, areas of conservation across divergent 
species would be the most likely target regions to convey function. Genomic comparison 
studies have identified many regulatory domains, which are essential for development 
(Woolfe et al., 2004). The benefits and applications of genomic comparisons are 
considerable, in this report we will focus on Lmx1b, a transcription factor associated with 
pattern formation of multiple organ systems with very few identified downstream targets.  
Lmx1b is a LIM homeodomain transcription factor known to contribute to 
patterning of the CNS, kidney, eye and limb in multiple species, however the mechanism 
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by which Lmx1b patterns these tissues is not fully understood. Lmx1b plays many 
important roles in CNS formation including development of the midbrain, hindbrain, 
serotonergic neurons and the differentiation/migration of spinal dorsal horn neurons. 
Lmx1b is expressed in the neural tube at the isthmus organizing center at 9 days post 
coitum (dpc) (Guo et al., 2007) where it acts to up-regulate Fgf8 and Wnt1 to ultimately 
determine the boundary between the midbrain and hindbrain (Canning, Lee, Irving, 
Mason, & Jones, 2007; Crossley, Martinez, & Martin, 1996; Wurst & Bally-Cuif, 2001). 
Lmx1b KO mice do not express Fgf8 or Wnt1a causing a severe reduction of the tectum 
and cerebellum (Guo, et al., 2007) conversely, overexpression of Lmx1b causes 
overexpression of Fgf8 and Wnt1 creating an expansion of the tectum and cerebellum 
(Matsunaga, Katahira, & Nakamura, 2002). Lmx1b also interacts with the transcription 
factor Pet1 to direct terminal differentiation and maintenance of serotonergic neurons 
(Cheng et al., 2003; Y. Ding et al., 2003). Additionally when Lmx1b is conditionally 
knocked out of Pet-1 expressing neurons all serotonergic neurons in the mouse brain are 
eliminated (Zhao et al., 2007; Zhao et al., 2006). It is thought that serotonergic 
dysfunction is associated with depression, post traumatic stress disorder and addiction 
(Naughton, Mulrooney, & Leonard, 2000). Interestingly the double Pet-1/Lmx1b KO 
mice seem to exhibit increased anxiety, possibly due to the loss of serotonin transmission 
(Dai, Hu, Shi, Guo, & Ding, 2008). Lmx1b KO mice do not form synaptic contacts 
between dorsal horn neurons and primary nociceptive afferent neurons, thus indicting that 
Lmx1b also plays a role in assembly of pain circuitry (Y. Q. Ding et al., 2004).   
The molecular mechanisms and pathways utilized by Lmx1b to regulate CNS 
development are still unclear. Since Lmx1b patterns several other organ systems studies 
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identifying downstream Lmx1b target genes in other systems may aid the discovery of 
CNS targets. Lmx1b has been well studied in the limb where microarray investigations 
using the Lmx1b KO mouse have implicated extracellular matrix molecules as 
downstream targets of Lmx1b during limb development (Feenstra et al., 2012; Gu & 
Kania, 2010; Krawchuk & Kania, 2008). In particular, the small leucine rich 
proteoglycan, Keratocan, was identified as a gene elevated in the presence of Lmx1b; and 
in Lmx1b KO embryos, Keratocan expression was not detected by whole mount in situ 
hybridization (Feenstra et al., 2012). 
In an effort to identify and characterize cis-regulatory regions that Lmx1b might 
utilize, we examined the genome surrounding Keratocan, which is flanked by its family 
members Lumican and Decorin forming the KLD locus. Using VISTA analysis revealed 
12 conserved noncoding regions (CNRs) surrounding the KLD locus. We screened 
several CNRs based on their location, the degree of conservation, and whether they 
contained an Lmx1b binding site.  We hypothesized that Lmx1b uses one of these CNRs 
to regulate Keratocan, Lumican, and/or Decorin during its multisystem development.  
 
Materials and Methods 
We identified conserved cis-regulatory regions surrounding the KLD locus using 
VISTA genome browser (http://pipeline.lbl.gov/cgi-bin/GenomeVista) which uses the 
human genome as a base to perform pairwise analysis with dog, mouse, opossum and 
chicken (Frazer, Pachter, Poliakov, Rubin, & Dubchak, 2004). Pink peaks of 
conservation indicate greater than 70% conservation over a 100 base pair segment. KLD 
locus pairwise analysis was performed by entering the human chromosomal location of 
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the KLD locus (Chromosome12: 89,900,717-91,055,428), this 1.15kb range represents 
the region of the KLD locus up to its nearest 5’ and 3’ gene. Peaks within this region that 
are at least 70% conserved in dog, mouse, opossum and chicken were labeled 1-12. Peak 
sequences for each species were examined for the FLAT Lmx1b binding site (TAATTA). 
Of the 12 peaks only Peak 3 and Peak10 contain a FLAT site overlapping the same 
region in human, dog, mouse, and chicken. Interestingly, the opossum shows a ~200 base 
pair frame shift from the other species.    
Forward and reverse primer sequences were generated which isolate CNR regions 
including an additional ~50bp outside the region producing an 878bp fragment for Peak 3 
and 894bp for Peak 10. Primer sets in the 5’ to 3’ orientation include;  
Peak 10 Forward – GCAAAGGAAATTTCTGGCTATC Peak 10 Reverse – 
GTTTTGAACCACCATAGTTGTCC Peak 3 Forward - 
CCTATTCATGACGCTGTTCATTTGC, and Peak 3 Reverse -  
GCAATCATTTCAAGCTTGAGAACC Primers isolated the Peak 3 sequence by PCR 
using chicken genomic DNA.  Forward and reverse oligomers 40 bp in length were 
annealed together to generate a 40 bp sequence that included the FLAT site in Peak 3, we 
also generated a mutant FLAT sequence (FLATmut) that contained the same region with 
the FLAT (TAATTA) site altered to form a HindIII cut site. 
Primer sets in the  5’ to 3’ orientation, FLAT and HindIII sites are in bold;  
FLAT Forward GCAGCTGCTAATTTGGTGATTAATTATCCATATTACACATTGA  
FLAT Reverse AGCAGCTGCTAATTTGGTGATTAATTATCCATATTACACATTG 
FLATmut Forward GCTGCTAATTTGGTGATAAGCTTTCCATATTACACATTGA 
FLATmut Reverse AGCTGCTAATTTGGTGATAAGCTTTCCATATTACACATTG 
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To generate FLAT and FLATmut fragments equimolar concentrations of forward 
and reverse primers were annealed using an annealing buffer (10 mM Tris, pH 7.5–8.0, 
50 mM NaCl, 1 mM EDTA) primers were boiled for 5 minutes then cooled to room 
temperature over a 60 minute period. The resulting annealed primer sets were used for 
further construct generation. Peak 3, FLAT and FLATmut fragments were ligated into the 
pCRTM II-TOPO (Invitrogen) vector using manufacture recommended protocol. 
Constructs were screened for insert and sent out to be sequenced (Eton biosciences). 
Sequence confirmed pCRTM II-TOPO constructs were cut using KpnI and XhoI, inserts 
were then ligated into a pTK-EGFP vector, an enhanced GFP reporter driven by the 
Herpes simplex virus thymidine kinase promoter (Uchikawa, Takemoto, Kamachi, & 
Kondoh, 2004). Peak 3 FLATmut construct was created with the Peak 3 pTK-EGFP 
plasmid as a template along with the Forward FLATmut primer using QuikChange Multi 
Site-Directed Mutagenesis Kit (Stratagene) per the manufacturer’s protocol.  
Whole embryo electroporation (HH4) is performed as described in (Chapman, 
Collignon, Schoenwolf, & Lumsden, 2001). 1μg of endotoxin free plasmid combined 
with Fas-green dye to visualize delivery is electroporated into the embryo using 5 pulses 
of 5 V for a duration of 50 ms at 100 ms intervals. Embryos are incubated on a yolk agar 
plate at 370C and construct activity (GFP) is visualized with fluorescent microscopy at 24 
and 48hrs. 
HH10 electroporation in ovo was performed to determine construct efficacy in the 
brain. Embryos/eggs were windowed, staged and stained with neutral red to facilitate 
electroporation and removal of the vitelline membrane surrounding the head. 1μg of 
endotoxin free plasmid and Fas green was injected into the neural tube lumen and pushed  
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Figure 5.1) Depictions of pTK-EGFP and HH4/HH10 Electroporation  
Since in silico analysis indicates Peak 3 and Peak 10 are likely targets of Lmx1b 
regulation we generated constructs for both CNR’s using a pTK-EGFP plasmid 
(Uchikawa, et al., 2004) which contains the the f1 phage origin; an upstream SV40; a 
multiple cloning site (MCS); the Herpes simplex virus thymidine kinase minimal 
promoter; an enhanced GFP reporter gene; and the ampicillin resistance gene (A). 
Electroporation of Peak 3 and Peak 10 into the whole embryo at the primitive streak stage 
allowed for detection of peak activity till HH14. Once the area of peak activity is 
determined, targeted regional electroporation (TREP) can be used to demonstrate activity 
in more developed organ systems such as the neural tube and developing brain (C).  
 
 
 
cranially toward the tip of the anterior neural pore.  Electrodes delivered 3 pulses of 50 
ms at 10 V at 100 ms intervals. Embryos are incubated and imaged with fluorescent 
microscopy at 24 and 48 hours to determine construct activity. 
Screening for activity in the limb was done by TREP of the lateral plate 
mesoderm between somites 14 and 21 in stage 14 chick embryos. Briefly, eggs are 
windowed and embryos stained with neutral red to determine somite number and assist 
removal of the vitelline membrane overlying the limb. Electroporation (EP) was 
performed with 3 pulses of 50 ms at 8 V at 100 ms intervals using 2 μg/μL and fas-green. 
Whole mount in situ hybridization (WMISH) was performed using antisense 
digoxigen-labeled RNA probes for chick LMX1B, KERATOCAN, LUMICAN and 
DECORIN. Chick LMX1B probe sequences: Forward – GGATCGCTTTCTGATGAGG, 
and Reverse - CGAATGGAAGGAATGATGACATC. KERATOCAN, LUMICAN, and 
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DECORIN probes were previously described (Dissertation Chapter 3, Feenstra et al 2012) 
Chicks embryos were harvested at HH19/20 and fixed overnight in MEMFA (0.1M 
MOPS, 2mM EGTA, 1mM MgSO4, 3.7% formaldehyde). WMISH was performed as 
described (Yamada, Szendro, Prokscha, Schwartz, & Eichele, 1999) with each probe 
hybridized at 60°C, and embryos were washed post hybridization at 65°C. 
 
 
Results 
Vista Analysis 
VISTA analysis encompassed a 1.15 kilobase region which compares the human 
KLD locus to the dog, mouse, opossum and chicken (Fig 5.2). Upstream of the KLD 
locus lies an area devoid of other genes also known as a gene desert. Gene deserts are  
 
 
 
 
 
Figure 5.2) VISTA Analysis of KLD Locus 
VISTA output of the KLD locus comparing human to dog, mouse, opossum and chicken. 
Numbers below represent 12 areas of conservation surrounding the KLD locus. 
Keratocan (Kera), Lumican (Lum) and Decorin (Dec) are labeled above the human 
genome (black line), analysis extends to 5’/3’ nearest neighbor genes. Pink peaks are 
conserved noncoding regions (CNR), dark blue regions are exons, light blue areas are 
untranslated regions. The horizontal line in each comparison represents 70% 
conservation. Peak 3 and Peak 10, highlighted in purple, contain conserved Lmx1b 
binding sites. Peak 10 is a small area of conservation between the 5’ untranslated region 
and first exon of Keratocan.   
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thought to be regions potentially rich with regulatory elements. Pink peaks denote areas 
of conservation; peaks with at least 70% conservation across species are labeled 1-12.  
Further analysis of Peak 3 and Peak 10 revealed each had an Lmx1b FLAT 
binding site (TAATTA), which is conserved from human to chicken, suggesting that 
Peak 3 and Peak 10 are likely sites for Lmx1b mediated regulation. Consequently, we 
isolated Peak 3 and Peak 10 to screen for localized activity in the developing chick 
embryo. 
 
Electroporation Studies 
 The conserved Peak 3 and Peak 10 sequences were incorporated into reporter 
constructs containing green fluorescent protein (GFP) driven by a basal herpes thymidine 
kinase promoter.  Without an associated enhancer, GFP expression from this plasmid is 
minimal. After generating our reporter construct, we performed whole embryo 
electroporation at the primitive streak stage just prior to gastrulation. Following 
electroporation further development of the embryos was accomplished by incubation on a 
yolk agar plate for 48 hours. GFP expression and thus, activity of the Peak sequences was 
screened by fluorescent microscopy at 48 hours or approximately HH14. Results of 
whole embryo electroporation reveal Peak 3 activity in the HH10 developing brain (Fig 
5.3A’). No activity of Peak 10 was identified after 48 hrs (Data not shown). To localize 
Peak 3 activity and correlate its activity with potential structure-related function in the 
brain, we performed electroporation during early brain development at HH10. Peak 3 
localized to the mesencephalon and diencephalon within the developing brain at HH19 
(Fig 5.3C’).  
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Figure 5.3) Peak 3 Activity in HH10 and HH19 Chick Brain 
A) Light microscopy, dorsal view of HH10 brain electroporated with Peak 3 plasmid at 
HH4, A’) GFP picture of same embryo shows Peak 3 activity in developing brain 
vesicles. B/B’) HH4 embryo electroporated with base pTK plasmid as a negative control 
C) Light microscopy, lateral view of HH19 chick head with Peak 3 neural tube targeted 
electroporation performed at HH10, C’) GFP denotes Peak 3 activity in the 
mesencephalon (Mes) extending slightly forward into the diencephalon (Die) but is 
excluded from the telencephalon (Tel).  
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Using targeted regional electroporation we transfected the lateral plate mesoderm 
of the chick wing at HH14 with Peak 3 and Peak 10. Embryos were imaged with 
fluorescent microscopy at 24, 48, 60 and 72 hours. No activity was detected for either 
Peak 3 or Peak 10 in the developing limb.   
Although Peak 3 activity was not detected in the limb, previously determined 
CNS activity (Fig 5.3) indicates Peak 3 may be a regulatory region for Keratocan (Kera), 
Lumican (Lum), and/or Decorin (Dec). To compare Peak 3 activity with LMX1B, KERA, 
LUM and DEC expression we performed whole mount in situ hybridization at HH19.  
 
Expression Pattern Profiles 
We confirmed the previously described expression of Lmx1b (Adams, Maida, 
Golden, & Riddle, 2000) in the mesencephalon and diencephalon. KERA, LUM and DEC 
are also expressed in the mesencephalon and diencephalon overlapping the areas of Peak 
3 activity (Fig 5.4). This convergence of proteoglycan expression and enhancer activity 
supports a common regulatory mechanism. Since Peak 3 contains an Lmx1b binding site  
 
 
Fig 5.4) WMISH of Lmx1b and Potential Downstream Target Genes 
WMISH detected LMX1B, KERATOCAN, LUMICAN and DECORIN in the 
mesencephalon (Mes), eye, telencephalon (Tel), and otic vesicle (OV). Mesencephalon 
expression overlaps Peak 3 activity. 
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we propose that Lmx1b binds the FLAT site to regulate the KLD proteoglycans. To test 
this possible mechanism of Lmx1b regulation we created a construct containing the Peak 
3 sequence with the FLAT site mutated to a HindIII cut site. Additionally we generated a 
small (40 bp) region containing the FLAT site and a corresponding region with the 
mutated FLAT site. 
 
FLAT Sequence Electroporation 
If Lmx1b utilizes the FLAT site to regulate Peak 3 activity then mutation of the 
Lmx1b binding site should alter or ablate Peak 3 activity. Similarly, if the sequence 
surrounding the FLAT site is the minimal sequence necessary for Peak 3 activity 
 
 
Figure 5.5) Activity of the Lmx1b Binding Site (FLAT)  
Conserved noncoding region, Peak 3, identified with Vista contains a known Lmx1b 
binding site, pink box/1 (FLAT). Mutation of the FLAT site is represented by the black 
box/black 2. Minimal (40bp) constructs were also generated containing the FLAT site (3) 
and the HindIII mutated FLAT site (4).  Embryos were electroporated at HH10 with the 
four constructs, followed by imaging with florescent microscopy to detect GFP at HH19. 
Peak 3 and FLAT constructs exhibit similar activity in the mesencephalon and 
diencephalon. Peak 3 FLATmut  and Flatmut both display expansion of activity into the 
telencephalon (white arrows).  
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electroporation of this minimal sequence (40bp) should show similar activity to the entire 
Peak 3 sequence. If Lmx1b binding is essential to Peak 3 activity then mutation of the 
FLAT site in both the entire Peak 3 and 40bp fragment should abate activity. 
Interestingly, we discovered the 40bp FLAT does mimic Peak 3 activity (Fig 5.5 1/3) 
while Peak 3 FLATmut and the 40bp FLATmut fragment have increased activity not 
only surrounding the brain vesicles of the tectum but also extending into the 
telencephalon where Lmx1b is not normally expressed (Fig 5.3 2/4). A possible reason 
for this outcome is that by mutating the FLAT site to a HindIII site we may have created 
a new transcription factor binding site with enhanced activity. 
To evaluate whether our mutation created a new binding site we used ALIBABA, 
a software program which uses TRANSFAC, a database of proven binding sites,  
 
 
Figure 5.6) ALIBABA Analysis of the FLAT and MutatedFLAT Binding Sites 
ALIBABA uses TRANSFAC analysis to determine possbile transcripution factor binding 
sites. Note Lmx1b is not listed in the TRANSFAC database and therefore does not appear 
in the results. Green region represents the FLAT site (TAATTA) while the red region 
below represents the FLAT site mutated to HindIII (mFLAT). In the native sequence we 
found five possible transcription factor biding sites in association with the FLAT binding 
site; our mutation of the FLAT binding site disrupted all five of these native sites, but 
generated 2 new binding sites.  
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consensus binding sites and regulated genes to discover predicted transcription factor 
binding sites. When we compare our FLAT and FLATmut sequences with ALIBABA, 
our mutation disrupted 5’ flanking binding sites; however, our mutation also generated 
new GATA and MCM1 binding sites (Fig 5.6). GATA transcription factors have been 
implicated in CNS development (Kornhauser et al., 1994), thus, creation of this new 
GATA site may have transformed the FLATmut sequence into an enhancer that is 
localizing to sites of GATA expression. 
 
 
Discussion 
 
Lmx1b is expressed in the isthmus organizer, a signaling center responsible for 
midbrain and hindbrain formation. Loss of Lmx1b causes a severe reduction of not only 
the midbrain dopaminergic neurons but also the tectum and cerebellum (Guo, et al., 
2007). We have discovered a conserved noncoding region (CNR), Peak 3, which contains 
an Lmx1b binding site and is active in the mesencephalon and diencephalon, tissues that 
will form the midbrain and hindbrain region. Peak 3 lies 5’ to Keratocan, Lumican and 
Decorin (KLD), we have also determined that KLD expression overlaps Lmx1b 
expression and Peak 3 activity in the brain. Additionally expression of the small 40bp 
fragment including the Lmx1b binding site FLAT showed the same activity as the entire 
Peak 3 indicating this sequence is sufficient for Peak 3 activity. Together these results 
suggest Lmb1b binds to Peak 3 thereby regulating the proteoglycans Keratocan, Lumican 
and Decorin during mid/hind brain development.  
No activity was detected for Peak 10 using whole embryo electroporation from 
HH4-HH14 and targeted regional electroporation of the limb from HH14-25. Although 
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Peak 10 may be active later in development our results suggest Peak 10 activity does not 
coincide with early stages of Lmx1b patterning.  
For the completion of this study we will generate a different mutation in the 
FLAT site to determine activity in both the 40 bp fragment and the full Peak 3 sequence. 
A loss of activity with the newly mutated FLAT site would suggest that the initial 
mutation and the binding sites generated expanded enhancer activity. We are also 
concurrently running a chromatin immunoprecipitation which isolates Lmx1b targeted 
sequences. We will screen our Lmx1b-immunoprecipitated chromatin for Peak 3 to 
determine direct Lmx1b binding. Although the FLAT site is the only currently known 
Lmx1b binding site it is likely that other Lmx1b binding sites remain to be determined. It 
is also likely that Lmx1b uses a currently unidentified binding site to regulate any of the 
remaining 10 CNR’s surrounding the KLD locus. We will also use the ChIP-seq results 
to screen for possible KLD-associated Lmx1b regulatory regions in the limb. 
  
115 
References 
 
Adams, K. A., Maida, J. M., Golden, J. A., & Riddle, R. D. (2000). The transcription 
factor Lmx1b maintains Wnt1 expression within the isthmic organizer. 
Development, 127(9), 1857-1867. 
Canning, C. A., Lee, L., Irving, C., Mason, I., & Jones, C. M. (2007). Sustained 
interactive Wnt and FGF signaling is required to maintain isthmic identity. 
Developmental biology, 305(1), 276-286. 
Chapman, S. C., Collignon, J., Schoenwolf, G. C., & Lumsden, A. (2001). Improved 
method for chick whole‚Äêembryo culture using a filter paper carrier. 
Developmental Dynamics, 220(3), 284-289. 
Cheng, L., Chen, C. L., Luo, P., Tan, M., Qiu, M., Johnson, R., & Ma, Q. (2003). Lmx1b, 
Pet-1, and Nkx2. 2 coordinately specify serotonergic neurotransmitter phenotype. 
The Journal of neuroscience, 23(31), 9961-9967. 
Crossley, P. H., Martinez, S., & Martin, G. R. (1996). Midbrain development induced by 
FGF8 in the chick embryo. 
Dai, J. X., Hu, Z. L., Shi, M., Guo, C., & Ding, Y. Q. (2008). Postnatal ontogeny of the 
transcription factor Lmx1b in the mouse central nervous system. The Journal of 
Comparative Neurology, 509(4), 341-355. 
Ding, Y., Marklund, U., Yuan, W., Yin, J., Wegman, L., Ericson, J., . . . Chen, Z. (2003). 
Lmx1b is essential for the development of serotonergic neurons. Nature 
neuroscience, 6(9), 933-938. 
Ding, Y. Q., Yin, J., Kania, A., Zhao, Z. Q., Johnson, R. L., & Chen, Z. F. (2004). Lmx1b 
controls the differentiation and migration of the superficial dorsal horn neurons of 
the spinal cord. Development, 131(15), 3693-3703. 
Feenstra, J. M., Kanaya, K., Pira, C. U., Hoffman, S. E., Eppey, R. J., & Oberg, K. C. 
(2012). Detection of genes regulated by Lmx1b during limb dorsalization. 
Development, growth & differentiation. 
Frazer, K. A., Pachter, L., Poliakov, A., Rubin, E. M., & Dubchak, I. (2004). VISTA: 
computational tools for comparative genomics. Nucleic Acids Research, 32(suppl 
2), W273-W279. 
Gu, W. X. W., & Kania, A. (2010). Identification of genes controlled by LMX1B in E13. 
5 mouse limbs. Developmental Dynamics, 239(8), 2246-2255. 
Guo, C., Qiu, H. Y., Huang, Y., Chen, H., Yang, R. Q., Chen, S. D., . . . Ding, Y. Q. 
(2007). Lmx1b is essential for Fgf8 and Wnt1 expression in the isthmic organizer 
116 
during tectum and cerebellum development in mice. Development, 134(2), 317-
325. 
Kornhauser, J. M., Leonard, M. W., Yamamoto, M., LaVail, J. H., Mayo, K. E., & Engel, 
J. D. (1994). Temporal and spatial changes in GATA transcription factor 
expression are coincident with development of the chicken optic tectum. 
Molecular brain research, 23(1-2), 100-110. 
Krawchuk, D., & Kania, A. (2008). Identification of genes controlled by LMX1B in the 
developing mouse limb bud. Developmental Dynamics, 237(4), 1183-1192. 
Matsunaga, E., Katahira, T., & Nakamura, H. (2002). Role of Lmx1b and Wnt1 in 
mesencephalon and metencephalon development. Development, 129(22), 5269-
5277. 
Naughton, M., Mulrooney, J. B., & Leonard, B. E. (2000). A review of the role of 
serotonin receptors in psychiatric disorders. Human Psychopharmacology: 
Clinical and Experimental, 15(6), 397-415. 
Uchikawa, M., Takemoto, T., Kamachi, Y., & Kondoh, H. (2004). Efficient identification 
of regulatory sequences in the chicken genome by a powerful combination of 
embryo electroporation and genome comparison. Mechanisms of development, 
121(9), 1145-1158. 
Woolfe, A., Goodson, M., Goode, D. K., Snell, P., McEwen, G. K., Vavouri, T., . . . 
Kelly, K. (2004). Highly conserved non-coding sequences are associated with 
vertebrate development. PLoS biology, 3(1), e7. 
Wurst, W., & Bally-Cuif, L. (2001). Neural plate patterning: upstream and downstream 
of the isthmic organizer. Nature Reviews Neuroscience, 2(2), 99-108. 
Yamada, M., Szendro, P. I., Prokscha, A., Schwartz, R. J., & Eichele, G. (1999). 
Evidence for a role of Smad6 in chick cardiac development. Developmental 
biology, 215(1), 48-61. 
Zhao, Z. Q., Chiechio, S., Sun, Y. G., Zhang, K. H., Zhao, C. S., Scott, M., . . . Gereau 
IV, R. W. (2007). Mice lacking central serotonergic neurons show enhanced 
inflammatory pain and an impaired analgesic response to antidepressant drugs. 
The Journal of neuroscience, 27(22), 6045-6053. 
Zhao, Z. Q., Scott, M., Chiechio, S., Wang, J. S., Renner, K. J., Gereau IV, R. W., . . . 
Chen, Z. F. (2006). Lmx1b is required for maintenance of central serotonergic 
neurons and mice lacking central serotonergic system exhibit normal locomotor 
activity. The Journal of neuroscience, 26(49), 12781-12788. 
  
117 
 
 
 
CHAPTER SIX 
 
IDENTIFICATION OF GENOMIC LMX1B BINDING SITES IN 
HUMAN EMBRYONIC KIDNEY CELLS 
 
 
 
 
 
Jennifer M. Feenstra1, Robert P. Stump1,2, Charmaine U. Pira1,  
Nathan R. Wall3, Kerby C. Oberg 1,4 
 
 
 
 
 
 
 
 
 
1Department of Pathology and Human Anatomy, Loma Linda University School of 
Medicine; 2Department of Biochemistry, Walla Walla University; 3Department of Basic 
Sciences, Loma Linda University School of Medicine, 4Department of Plastic and 
Reconstructive Surgery, Loma Linda University School of Medicine. 
 
 
 
 
 
*Correspondence:   
Kerby C. Oberg, MD, PhD 
Department of Pathology and Human Anatomy 
24785 Stewart Street,  
Loma Linda, CA  92350 
Tel (909) 558-7212  
Fax (909) 558-0439 
Email – koberg@llu.edu   
118 
Abstract 
 
Lmx1b is a homeodomain transcription factor critical to kidney development and 
glomerular filtration.  In humans, Lmx1b haploinsufficiency causes a condition known as 
Nail-Patella syndrome (NPS).  Individuals with NPS typically have under-developed 
nails, absent patellae, and impaired kidney function.  In Lmx1b knockout mice, the 
absence of Lmx1b function disrupts glomerular filtration and abates urine production.   
The molecules targeted by Lmx1b that regulate glomerular development and function, 
however, are poorly characterized. Immortalized human embryonic kidney (HEK 293) 
cells provide a potential tool for high-throughput identification of Lmx1b targets and an 
in vitro system for dissecting the functional role of targets.  Thus, we characterized the 
known Lmx1b pathway in HEK 293 cells and evaluated sites of Lmx1b binding.   We 
demonstrate the expression of Lmx1b and its renal targets, collagen 4 alpha 4 (Col44) 
and podocin (Nphs2) in HEK 293 cells by RT-PCR.  Additionally, protein expression of 
Lmx1b was verified by western blot analysis.  In a preliminary Chromatin 
immunoprecipitation, we determined that Lmx1b binds to regulatory sequences 
associated with Col44 and Nphs2. Further characterization of the Lmx1b pathway in 
HEK 293 cells is underway and will likely enhance identification of relevant downstream 
Lmx1b targets. 
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Introduction 
 
Throughout development, molecular pathways are routinely reused to pattern 
various organs or structures. Thus key molecules used in these pathways must be capable 
of patterning multiple organ systems. One such example is Lmx1b, a LIM-homeodomain 
transcription factor critical for central nervous system (CNS),  eye, limb, and kidney 
development. Absence of Lmx1b function in Lmx1b knockout (KO) mice disrupts CNS 
development, limbs exhibit a distal ventral-ventral symmetry and the kidneys are small, 
lack proximal tubules and fail to produce urine (Chen, et al., 1998). Lmx1b KO mice die 
shortly after birth due in part to the nephropathy The filtering units of the kidney are 
convoluted vascular tufts of capillaries called glomeruli. Podocytes are a specialized type 
of epithelial cell that wrap around glomerular capillaries to regulate filtration.  Podocytes 
secrete basement membrane components including collagens and proteoglycans. During 
kidney development Lmx1b directs podocyte differentiation and maintenance. Loss of 
Lmx1b causes aberrant basement membrane formation, thereby preventing normal 
glomerular filtration (Rohr, et al., 2002). Despite many years of study, only two direct 
downstream targets of Lmx1b have been discovered, Col44 (Morello, et al., 2001) and 
Nphs2 (Rascle, et al., 2009), while other targets in the kidney remain elusive. In other 
organs patterned by Lmx1b, no other direct downstream targets have been confirmed. 
Although, recent microarray studies in the limb have implicated the proteoglycans 
Keratocan, Lumican, and Decorin, it is unclear whether these molecules are direct or 
indirect targets (Feenstra, et al., 2012). Interestingly, disruption of Lmx1b patterning 
causes abnormal patterning of extracellular matrix proteins in the kidney and limb. So it 
may be that discovery of downstream Lmx1b targets in the kidney will enhance and/or 
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identify new limb targets.  
Keratocan, Lumican and Decorin are a unique set of small leucine rich 
proteoglycans tightly clustered together on the genome. Keratocan is best known for its 
role in maintaining transparency in the lens of the eye by aiding collagen fibril 
development and maintenance (Liu, et al., 2003). Lumican and Decorin are also 
associated with collagen fibrillogenesis; in particular affecting the rate of collagen fibril 
assembly, thereby giving tendons and skin their tensile strength (Rada, Cornuet, & 
Hassell, 1993). Lumican and Decorin are both expressed during kidney development and 
have been studied in the adult human diabetic kidney where overexpression of Lumican 
and Decorin is thought to have a protective effect (Schaefer et al., 2001).  Upstream of 
the Keratocan, Lumican, and Decorin locus lies a 900 kb non-coding region, which 
contains developmentally conserved sequences. One region (800bp), which we named 
Peak3, contains an Lmx1b FLAT binding site (TAATTA) and is conserved between 
human, mouse, dog, opossum and chicken. These three proteoglycans clustered on the 
genome in conjunction with a conserved Lmx1b binding site and changes in proteoglycan 
distribution in the Lmx1b KO mouse makes Peak3 a compelling regulatory target in the 
Lmx1b cascade. We hypothesize that Lmx1b regulates Keratocan, Lumican and Decorin 
(KLD) by binding to Peak3 during development.  
In an effort to characterize downstream targets of Lmx1b, including Peak3, we 
will use chromatin immunoprecipitation in conjunction with next generation sequencing 
(ChIP-seq). ChIP-seq will help us determine Lmx1b regulation by defining genomic sites 
of Lmx1b binding associated with its regulated targets. This is an important step in 
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beginning to understand the mechanisms utilized by the Lmx1b to regulate morphology 
and function. 
 
Methods 
Cell Culture 
 
Human embryonic kidney cells (HEK) 293 cells were grown in 75 cm2 culture 
flasks and maintained at 37oC in a humidified incubator with 5% CO2. Cells were 
cultured in Dulbecco's Modified Eagle Medium (DMEM/ATTC) supplemented with 10% 
fetal bovine serum (Atlanta Biologicals). A subset of HEK cells were transfected with an 
pOZ-N-Lmx1b construct which contains both hemagglutinin (HA) and FLAG tags 
flanking the Lmx1b (pOZ-Lmx1b-HA/FLAG, generated in collaboration with Dr. Nathan 
Wall). 
 
HEK Cell Characterization 
 
HEK cell DNA was isolated using the DNeasy per manufacturers protocol 
(Qiagen,). Primers to flank the Lmx1b binding site of Col4and Nphs2 were generated 
and resulting PCR amplicons were purified and sequenced (Eton Bioscience Inc.) to 
determine specificity. Primers were also generated to pull down RNA sequences for 
Col44 and Nphs2, which were also purified and sequenced.  
 
Western Blot 
 
HEK cells were homogenized via sonication in lysis buffer containing 1% Triton 
X-100, 0.5% sodium deoxycholate, 0.1% SDS, 150 mM NaCl, and 50 mM Tris (pH 8). 
Protein (15-20 ul) was loaded into duplicate lanes of a 4-12 % Tris-glycine SDS-PAGE 
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gel (Invitrogen, Carlsbad, CA). Each electrophoresis and blotting was performed using 
nitrocellulose membranes at least twice. Membranes were stained with Ponceau S 
solution (0.1% Ponceau in 5% acetic acid) to check for variance in sample loading. The 
membranes were washed in 20 mM Tris-buffered saline solution with 0.1% Tween 20 (T-
TBS). Membranes were blocked in 5% powdered milk in T-TBS for 1 h at room 
temperature and washed three times in T-TBS before being incubated overnight in 
primary antibody solution (Lmx1b AB, donated by the Ralph Witzgall lab, diluted 
1:10/Hemagglutinin AB, Sigma, diluted 1:250). After incubating in the primary antibody, 
all membranes were washed three times in T-TBS and incubated in LI-COR® IRDye® 
800CW Goat Anti-Mouse IgG or 680CW Goat Anti-Rabbit IgG (LI-COR®, Lincoln, 
NE; T-TBS, 1:15:000) for 1 h at room temperature. LI-COR® Odyssey® Fc Imaging 
System was used for detection of the protein bands. 
 
 
Chromatin Immunoprecipitation (ChIP) 
 
Cells were fixed with formaldehyde and chromatin extracted and sheared to 
produce chromatin fragments of 500-250 bp (optimized as per protocol, ChIP-it Express 
Enzymatic, Active Motif, Carlsbad, CA). The DNA concentration in the sheared 
chromatin was determined using the Nanodrop spectrophotometer. Approximately 50 ug 
of sheared chromatin was used for each immunoprecipitation. We isolated chromatin 
using the HA (Sigma) antibody from HEK cells and transfected Lmx1b-HA HEK cells. 
We also used the control kit (Active Motif) containing a Gapdh primer set, the RNAPolII 
antibody for use as an in-run positive control and IGG as an in-run negative control. The 
ChIP-Express system uses protein G magnetic beads to precipitate antibody bound to 
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chromatic allowing for rapid purification of the protein-DNA complexes. The ChIP-
isolated DNA was then purified using the minelute QIAquick PCR purification system 
(Qiagen) and DNA concentration determined using the Nanodrop spectrophotometer. 
Quality control check of all ChIP DNA (input chromatin, HEK, Ha-Lmx1b HEK) 
included PCR for 5’ region of Gapdh and known Lmx1b binding targets Col44 and 
Nphs2.  
 
ChIP Sequencing 
 
We will use the University of California at Irvine (UCI) Genomics High 
Throughput Facility for sequencing (http://ghtf.biochem.uci.edu/); they use an Ilumina 
high throughput DNA sequencer (HiSeq 2000). We will submit 50 ng of ChIP-isolated 
DNA from our HEK and Lmx1b-HA HEK cell lines. HEK cell chromatin isolated with 
the HA antibody results will help identify nonspecifically bound chromatin. Results will 
be compared to previously identified conserved non-coding regions upstream of the KLD 
locus. In addition, results will be analyzed with the Genomic Regions Enrichment of 
Annotations Tool. This online software tool 
(http://great.stanford.edu/public/html/index.php) compares the location and association of 
potential regulatory elements with the annotations of the surrounding or nearby coding 
genes and assigns potential functional relevance to the site of binding. 
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Results 
HEK Cell Characterization 
 Previous studies have shown that Lmx1b binds the FLAT site upstream of human 
Col44 (Morello, et al., 2001) and Nphs2 (Rascle, et al., 2009) using Cos7 and Hela cell 
lines. We suggest that the Human Embryonic Kidney cell line (HEK) would more 
accurately represent Lmx1b regulation in the developing human kidney. We began 
characterization of HEK cells by demonstrating that Lmx1b, Col44, and Nphs were all 
normally expressed (Fig 6.1B).  We further isolated the previously described FLAT 
Lmx1b binding sites associated with Col44 and Nphs2 (Fig 6.1A).  
 
 
 
Figure 6.1) Characterization of Human Embryonic Kidney Cell Line 
A.) PCR of Lmx1b and the FLAT sequence of its renal targets, Collagen 44 and 
Podocin (Nphs2) using HEK 293 cell DNA. Gapdh was used as a positive control. B.) 
PCR of RNA from Collagen 44 and Nphs2 using HEK cell cDNA. C.) Demonstration 
of LMX1B in HEK 293 cells transduced with HA-LMX1B (293/L) by Western blot. HA-
tagged LMX1B is demonstrated by both HA antibodies (HA) and LMX1B antibodies 
(LMX1B) (arrow ~56 kDa) 
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To enable optimization of the ChIP-seq protocol without depleting our limited 
supply of the ChIP proven Lmx1b polyclonal antibody, we transfected HEK cells with a 
pOZ-Lmx1b-HA construct. Generation of a stable HEK293 cell line with this construct 
(HEK293/L) allows us to probe for Lmx1b specific targets using commercially available 
ChIP proven monoclonal antibodies to either the HA epitope or the FLAG epitope.  
Using the Lmx1b antibody, Lmx1b protein was detected by western blot in both HEK293 
and HEK293/L transfected cell lines (Fig 6.1C). Note, the construct generates greater 
than10 times more Lmx1b that endogenously present.  Thus the enhanced Lmx1b protein 
levels in the HEK293/L cells (Fig 6.1 +) by western analysis overshadows the level of 
Lmx1b protein visualized in control HEK cells (Fig -) although it is readily detected by 
Odyssey® Fc Imaging System (data not shown).  While using the HA antibody, only the 
HEK293/L cells demonstrate Lmx1b protein (Fig 6.1 +).  Importantly, the background 
HA recognized proteins in HEK293/L are also recognized in the control HEK293 cells 
(Fig6.1-).  
The HEK cell line mimics in vivo conditions making it an accurate reproducible 
model of Lmx1b mediated kidney development, which can be use for ChIP-seq. We were 
able to enhance Lmx1b protein levels in the HEK293/L cell line. Thus, using this model 
for Chip will accentuate Lmx1b targets. The unaltered HEK cell line will be used as a “in 
run” negative control since we were unable to detect Lmx1b protein with the HA 
antibody.  
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Preliminary ChIP Results 
We confirmed the effectiveness of this approach by performing a chromatin 
immunoprecipitation to the known renal Lmx1b binding sites.  Lmx1b bound chromatin 
was isolated, fragmented and then enriched from HEK293 and HEK293/L cells using an 
HA antibody. PCR confirmed the presence of Lmx1b binding sites (FLAT) to COL44 
and Nphs2 from HEK293/L cells (Fig 6.2). FLAT sites were not found in control 
HEK293 cells isolated with the HA antibody. 
 
Figure 6.2) ChIP Results from HEK and HA-LMX1B Transduced HEK Cells 
PCR following HA-immunoprecipitation (HA Ab) of human embryonic kidney (HEK) 
293 cells containing the HA-LMX1B construct. Lmx1b binding sites in kidney COL44 
(C) and NPHS2 (N) loci are recovered by PCR. Sheared input DNA demonstrates the 
PCR fragment size of the predicted sites. The positive control uses an RNA polymerase II 
antibody (RP Ab) that binds to a GAPDH associated site (G) M=Molecular weight 
markers. Note absence of LMX1B COL44 and NPHS2 sites in the control HEK 293 
cells using HA antibody ( ). 
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Discussion 
 
Characterization of the Lmx1b pathway in HEK293 cells will facilitate identification 
of downstream targets and the molecular cascade that regulates glomerular development 
and function. We have successfully isolated the FLAT sequences from Col44 and 
Nphs2 from HEK cell DNA. We have also shown Lmx1b, Col44 and Nphs2 RNA 
expression in the HEK cell line. Using western blot we detected Lmx1b protein in both 
the HEK and HEK transfected cell lines. Together these results indicate that the HEK cell 
line mimics in vivo conditions and is therefore a good model to perform ChIP-seq. PCR 
following ChIP confirmed Lmx1b binding to FLAT regulatory regions of both Col44 
and Nphs2.   
 
To complete this project we will perform multiple ChIP runs to pool the chromatin 
thereby allowing for sufficient chromatin to be isolated for sequencing. We expect ChIP-
seq results to partially overlap microarray results discussed in Chapter 3. We also expect, 
since Peak3 is a very likely target of Lmx1b regulation, sequencing results from ChIP 
HA isolated chromatin will include Peak3 discussed in Chapter 5. Isolation of this region 
with ChIP will help determine direct Lmx1b binding.  
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CHAPTER SEVEN 
 
CONCLUSION AND FUTURE DIRECTIONS 
 
 
Conclusion 
 Lmx1b is a homeodomain transcription factor necessary and sufficient for 
dorsalizing distal limb structures.  This was established over a decade ago with the 
production of an Lmx1b knockout mouse (Chen et al., 1998). However, downstream 
targets of Lmx1b in the limb responsible for dorsalization remain uncharacterized. We 
began our search for Lmx1b target genes using the Lmx1b KO mouse model. In the 
mouse, loss of Lmx1b causes scapular hypoplasia, distal ulnar hypoplasia, and loss of 
soft tissue dorsalization, i.e., symmetrical ventral-ventral or flexor-flexor ligaments, 
tendons and muscles (Chen & Johnson, 2002).  Using microarray comparison of Lmx1b 
KO and wildtype limbs we discovered skeletal, connective tissue, neuronal, and 
angiogenic targets differentially expressed during Lmx1b mediated limb dorsalization. 
One of the most noteworthy findings of our microarray analysis was the discovery of 
several proteoglycans and proteoglycan related genes regulated by Lmx1b. The persistent 
asymmetrical elevation of a cluster of proteoglycans during limb dorsalization may 
provide clues to the mechanism of Lmx1b-regulated patterning.  
We focused our efforts on the proteoglycans Keratocan, Lumican and Decorin for 
several reasons: the preponderance of proteoglycan and proteoglycan associated genes 
discovered in the microarray analysis, of all the downstream targets discovered, 
Keratocan showed the greatest fold change in the microarray, all three proteoglycans 
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have a dorsally restricted expression pattern in the limb while Keratocan was 
undetectable in the Lmx1b KO mouse limb, these three proteoglycans (Keratocan, 
Lumican and Decorin) are closely arranged on the genome (the KLD locus) suggesting a 
common or redundant mechanism of regulation and finally surrounding the KLD locus 
are two regions highly conserved across species which contain an Lmx1b binding site.  
The role of Lmx1b mediating limb dorsalization is conserved across vertebrate 
species (Mercader, 2007). Since the developing chicken limb in ovo is accessible and 
provides a model to perform temporal and spatial experimentation we continued 
examination of the proteoglycans using the chick limb. We confirmed similar expression 
of Lmx1b expression within the dorsal mesoderm of mouse and chicken limbs. 
Unexpectedly however, the progressive patterns of Keratocan, Lumican and Decorin 
expression were not conserved between chick and mouse limbs although, in both species, 
these proteoglycans do eventually localize to tendons.  The disparate patterns of 
proteoglycan expression suggest that mechanisms regulating these genes are not fully 
conserved.   
 Nevertheless, Keratocan demonstrated the greatest fold change in the microarray 
analysis, was undetectable in the Lmx1b KO mouse and is flanked by two conserved 
noncoding regions (CNRs), that contain Lmx1b binding sites.  Peak 3, is upstream of the 
KLD locus and exhibits enhancer activity in the mesencephalon and diencephalon, tissues 
that will form the midbrain and hindbrain region. Correspondingly Lmx1b, Keratocan, 
Lumican and Decorin are expressed in the isthmus organizer, a signaling center 
responsible for midbrain and hindbrain formation. Loss of Lmx1b causes a severe 
reduction of not only the midbrain dopaminergic neurons but also the tectum and 
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cerebellum (Guo et al., 2007). In addition, activity of a small 40 base pair fragment rich 
in potential binding sites, including the Lmx1b binding site (FLAT), displayed the same 
activity as the entire Peak 3, suggesting that this was the minimal sequence necessary for 
Peak 3 activity.  The activity of KLD-associated Peak 3 localized to Lmx1b-dependant 
CNS structures during development supports a direct role for Lmx1b regulation. Together 
these results suggest Lmx1b binds to Peak 3 thereby regulating the proteoglycans 
Keratocan, Lumican and Decorin during midbrain and hindbrain development.  Our limb 
focused data also suggested that Lmx1b regulates morphogenesis by altering 
proteoglycan composition.  Collectively, our CNS and limb related studies suggest that 
modulation of proteoglycan composition is one mechanism whereby Lmx1b can regulate 
morphogenesis.   
 
Future Directions 
 
The proteoglycans Keratocan, Lumican and Decorin lie very close along the 
genome suggesting a similar or redundant function. Although individual knockout mouse 
models exist for each of these genes, a compound KLD KO mouse would help determine 
the function of these molecules.  It is unlikely that a triple KO of Keratocan, Lumican and 
Decorin KO could be accomplished by breeding individual KO mice, due to the close 
proximity of these genes within the KLD locus (within 60 kb of each other). I would 
propose that removal or disruption of the entire KLD locus would save resources and 
time.  If KLD’s regulation by Lmx1b is critical for limb development, then the KLD KO 
mouse would present with aberrant dorsal limb morphology. It is likely that other Lmx1b 
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patterned tissues including the eye, midbrain/hindbrain and kidney would also be 
disrupted. 
 In addition to the proteoglycans examined in this dissertation, many other 
interesting downstream Lmx1b targets were discovered in the microarray analysis 
(Chapter 3). An interesting group that remains to be examined are genes associated with 
scapula formation.  Agc, Lum, Dec, and Lox show a reduction of scapular expression in 
Lmx1b KO mice while Emx2, Matn1, and  Matn4 exhibited a striking loss of scapular 
expression. Since Lmx1b KO mice have hypoplastic scapulae, we propose Lmx1b works 
in concert with these collective targets to augment scapular development. An interesting 
way to examine Lmx1b effect on scapula development would be to knockout Lmx1b 
expression from condensing cartilage. A recent study attempted this using a Sox9 
promoter to induce Cre Lox removal of Lmx1b, the phenotype was very mild presenting 
with distal ventralized sesmoid bones (Li, Qiu, Watson, Schweitzer, & Johnson, 2010). 
Use of a similar method with an earlier marker to drive Lmx1b KO in the limb and 
scapula cartilage would be a very interesting model to study the effects of Lmx1b on 
skeletogenesis. Similarly a Scleraxis driven conditional Lmx1b KO would help to 
determine the role of Lmx1b and the downstream targets we discovered which localize to 
tendons.  
 Chip-seq data will be overlaid with the microarray data to confirm direct 
downstream targets. Initially ChIP-seq will be done using kidney cells, thus it is likely 
that not all relevant limb targets will overlap. However, with the confirmation of direct 
downstream Lmx1b targets in the limb we can proceed with ChIP-seq using mouse limb 
chromatin. Using our mouse colony we can harvest chromatin directly from mouse limbs 
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during Lmx1b mediated dorsalization. However since we have a limited amount of ChIP 
proven Lmx1b antibody available we may also use a transgenic mouse created by Dr. 
Randy Johnson with a Hemagglutinin tagged Lmx1b. Access to this breeding mouse 
colony would allow us to perform the ChIP on mouse limb chromatin using the Chip 
proven hemagglutinin antibody. 
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Abstract 
Recent investigations into the mechanism of limb development have clarified the 
role of several molecules, their pathways and interactions.  Characterization of the 
molecular pathways that orchestrate limb development has provided insight into the 
etiology of many limb malformations.  In this review, we describe how the insights from 
developmental biology are related to clinically relevant anomalies and the current 
classification schemes used to define, categorize, and communicate patterns of upper 
limb malformations.  We advocate an updated classification scheme for upper limb 
anomalies that incorporates our current molecular perspective of limb development and 
the pathogenetic basis for malformations using dysmorphology terminology. We 
anticipate that this scheme will improve the utility of a classification as a basis for 
diagnosis, treatment and research.  
 
Introduction 
Around 1 in 600 newborns present with some form of upper limb abnormality (1). 
The molecular mechanisms that orchestrate limb development have been the focus of 
intense study for several decades.   Recent discoveries provide a more comprehensive 
understanding of the process and greater insight into how disruption of different 
molecular pathways correlates with specific presentations of upper limb anomalies.   
Clinical diagnosis and treatment is enhanced by an accurate method to describe 
and categorize these anomalies.  Furthermore, there is a benefit for communication 
between various clinicians and basic scientists if the classification scheme incorporates a 
contemporary understanding of the developmental process.  The most commonly used 
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classification at present is based on a scheme proposed by Swanson (2) in 1964  and was 
subsequently accepted by the International Federation of Societies for Surgery of the 
Hand (IFSSH) in 1974 (3).  This classification scheme merged the morphological 
understanding of limb development with a surgical perspective on treatment.  Its 
simplicity promoted near universal adoption.  However, its simplicity fails to group some 
developmentally related anomalies, thereby allowing for either misdiagnosis or multiple 
diagnoses for a related condition.  Importantly, the scheme intermixes descriptive and 
presumed etiologic categories.  Its descriptive terminology is unable to incorporate 
changes based on our increased understanding of developmental biology.  Consequently, 
this method of classification has generated criticism (4-9).   
Despite continued progress in limb development research, a comprehensive 
picture that explains a large spectrum of upper limb malformations has only recently 
emerged.  Manske and Oberg recently proposed several modifications to the 
classification scheme based on clinical experience and developmental biology (6).  The 
intent of this review is to present an overview of developmental biology highlighting 
current concepts of the pathogenetics of limb anomalies and to provide support for 
further modifying the classification scheme to make it more relevant and useful.   
 
Limb Development – Axis Formation and Differentiation 
During early embryonic development, homeobox (HOX) transcription factors set 
up a segmental body plan along the cranial-caudal axis (10).  Around the fourth week of 
development, the presumptive upper limb fields are established, triggering the expression 
of TBX5, WNT and FGF proteins that initiate limb outgrowth (11).  The upper limb bud 
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emerges as a bulge of lateral plate mesoderm covered by a thin outer layer of ectoderm 
(Fig A.1).  Failure of limb induction, or tetramelia, is associated with WNT3 and FGF10 
mutations (12;13).  TBX4 and TBX5 provide clues for hindlimb\forelimb identity, 
respectively.  Mutations in TBX5 (Holt-Oram syndrome) (14) produce a range of upper 
limb anomalies.  
Following formation of the limb bud, development proceeds along three axes:  
proximal-distal, anterior-posterior (radial-ulnar), and dorsal-ventral (Fig A.1).  
 
 
 
Figure A.1) Limb Bud Coordinate Axes and Signaling Centers 
A) The forelimb (boxed region) of a Carnegie stage 13 embryo depicting the three 
coordinate axes – each with their own signaling center: the apical ectodermal ridge (AER 
- orange) coordinating proximal-distal (Pr-Di) outgrowth and differentiation; Radial-ulnar 
asymmetry  is controlled by the zone of polarizing activity (ZPA - purple).  Dorsal-
ventral (Do-Ve) asymmetry is regulated by dorsal ectoderm (green); Within the progress 
zone (PZ - blue) the fate of mesodermal cells are determined by these signaling centers.  
The axes and signaling centers are shown in different orientations – B) Dorsal view, and 
C) Lateral, end on view.  (Modified from Oberg et al., 2004, used with permission) 
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Development and differentiation of each axis is controlled by a population of cells that 
signal patterning information to local cells and organize tissue along its axis, i.e., 
signaling centers.  Mesodermal FGF10, in conjunction with ectodermal radical fringe (R-
FNG) at the apical dorsal-ventral boundary, induces ectodermal thickening to form the 
signaling center for the proximal-distal axis, the apical ectodermal ridge (AER) (15-17).  
The AER, in turn, secretes WNT3 and several FGF proteins (FGF4, 8, 9 & 17), which 
maintain FGF10 expression in the underlying mesoderm.  FGF10 sustains the 
proliferation of a sub-AER population of cells termed the “progress zone” (PZ) (18).  The 
mesodermal cells within the PZ are influenced by the signaling centers to determine their 
ultimate fate.  This reciprocal loop of ectodermal and mesodermal FGF/WNT proteins 
maintains proximal-distal outgrowth (Fig A.2 A) (19;20).   
Development and differentiation along the anterior-posterior (radial-ulnar) axis is 
controlled by the zone of polarizing activity (ZPA) in the posterior (ulnar) limb 
mesoderm.  The ZPA expands limb width and posteriorizes (ulnarizes) the developing 
limb through a secreted morphogen, sonic hedgehog (SHH) (Fig. 2B & C) (21).  The 
AER and the ZPA are closely linked by a reciprocal feedback loop that maintains SHH 
expression at the distal posterior (ulnar) border of the AER during progressive outgrowth 
(22-24).   
WNT7A secretion in the dorsal ectoderm regulates limb development along the 
dorsal-ventral axis.  WNT7A dorsalizes the underlying limb mesoderm through the 
induction of the Lim homeodomain transcription factor LMX1B (Fig A.2 D) (17;25;26).   
Disruption of WNT7A also disrupts ulnarization indicating an important role for WNT7A 
in maintaining ZPA-related secretion of SHH (27).  Thus, SHH plays a pivotal role 
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during limb development, linking proximal-distal, anterior-posterior (radial-ulnar), and 
dorsal-ventral axes during outgrowth (28).  
The signaling centers are involved in the coordinate control of downstream targets 
involved in skeletogenesis, vasculogenesis, myogenesis, and innervation, which may 
involve both common, and unique, asymmetric molecular pathways.  For example, 
skeletogenesis requires appropriate temporal and spatial regulation of multiple factors 
including SOX9 for condensation of skeletal anlagen; WNTs and GDF5 for joint 
formation; and PTHLH, IHH, IGFs, BMPs, WNTs, FGFs, and RUNX2 for anlagen 
growth and subsequent endochondral ossification (29).  In addition, SHOX2 is up-
regulated in the proximal perichondrium and promotes humeral elongation, while SHOX 
is induced in the forearm perichondrium and regulates radial-ulnar elongation (30;31).  
Thus, appropriate induction of downstream pathways is critical to complete 
differentiation along the appropriate limb axis.     
 
Disruption of the Proximal-Distal Axis (Transverse Deficiencies) 
FGFs emanating from the AER promote PZ and ZPA related limb outgrowth.  
Complete removal of the AER (32) or blockade of FGF-receptor signaling (33;34) 
truncates the limb along the proximal-distal axis coincident with the timing of disruption 
(Fig A.2 E).  These truncated limbs are akin to those described clinically for transverse 
arrest and the data in animal models suggest that the level of truncation/transverse arrest 
correlates with the timing of disruption (35).   
Recently, Winkel and colleagues (36) demonstrated a link between WNT 
signaling and ROR2, the receptor tyrosine kinase frequently mutated in brachydactyly 
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type B1 (BDB1).  WNTs, under the control of AER-related FGFs, contribute to 
elongation of the entire limb via ROR2 receptors; thus linking abnormal function of the 
AER outgrowth pathway to this form of brachydactyly and providing impetus for 
inclusion as a disruption of proximal-distal development.   
Intersegmental defects or phocomelias have been difficult to align with 
developmental pathways and most of these fall under severe longitudinal or radial-ulnar 
axis defects as described below.  However, recent insights into the mechanisms and 
potential roles of SHOX2 and SHOX in proximal-distal outgrowth may support some 
rare intersegmental defects (30;31;37).   
 
Disruption of the Radial-Ulnar Axis (Longitudinal Deficiencies) 
Whereas complete elimination of AER-related FGF function leads to transverse 
deficiencies, reduction in FGF function produces longitudinal deficiencies (Fig. 2F).  
Diminished FGF function leads to a reduction in limb outgrowth, volume and width, 
although proliferation and ulnarization promoted by the ZPA persists.  The resulting 
phenotypes are remarkably similar to the classification spectrum of radial longitudinal 
deficiencies (RLD) (Fig A.2 F) (38-40).  Malformation syndromes with mutations in FGF 
receptor-2, such as Apert, Pfeiffer or Saethre-Chotzen, also link radial/anterior joint 
abnormalities and synostoses of the arm to regulation of the FGF pathway (41).   
SHH induces ulna formation in the forelimb and 4 ulnar-sided digits in the hand.  
In addition, SHH is responsible for posterior (ulnar-sided) limb growth and expansion.  
Progressive loss of SHH expression or targeted temporal interruption of SHH signaling 
during limb development reduces limb outgrowth, volume and width (42;43).  The 
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phenotypes generated with SHH loss mimic those described in the spectrum of ulnar 
longitudinal deficiencies (ULD) (Fig A.2 G).  The clinical spectrum of ULDs probably 
reflects variation in the timing, degree and duration of SHH disruption.  Furthermore, the 
loss of SHH can also reduce FGF expression via interruption of the SHH-FGF loop.  
Thus, with reduced limb width, limb volume and FGF expression, formation of radial 
structures, particularly the thumb, can also be undermined.  This correlates with the 
common clinical presentation of thumb deficiencies associated with ULD.   
In the past, severe forms of longitudinal deficiencies that involve proximal losses 
have been classified as intercalary or intersegmental defects.  Careful reexamination of 
many of these cases demonstrates distal defects consistent with RLD or ULD suggesting 
that the proximal abnormalities represent a continuation of the longitudinal deficiency 
(44;45).   
 
Disruption of the Dorsal-Ventral Axis (Dorsalization Deficiencies) 
Reduction or loss of either WNT7A in the dorsal ectoderm or LMX1B in the 
dorsal mesoderm impairs dorsalization (Fig A.2 H) (46;47).  In the mouse model, 
haploinsufficiency does not generate a phenotype; however, in humans, single allele 
disruption of LMX1B has been shown to cause Nail-Patella Syndrome, with reduced 
limb dorsalization, i.e., abnormal elbow and fingernail formation (47). (dorsalization is 
the embryonic term used prior to limb rotation and subsequently refers to the posterior or 
extensor aspect of the upper limb and the anterior-extensor aspect of the lower limb) 
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Figure A.2) Disruption of Axis Formation/Differentiation 
A-D) Impact of signaling centers on normal development . A) Fibroblast growth factors 
(FGFs) from the AER (orange) initiate and maintain limb outgrowth. Formation of 
skeletal elements progresses from proximal to distal shown in three progressive stages 
that depict arm, forearm and hand formation.  B) During limb outgrowth sonic hedgehog 
(SHH) emanating from the ZPA (purple) establishes an “ulnarizing” gradient (purple 
arrows) and maintains posterior (ulnar) proliferation.  In addition, FGFs (orange arrows) 
secreted from the AER promote proliferation in the underlying progress zone 
contributing to limb volume and width.   C) Relative contributions of SHH (purple) and 
FGFs (orange) to skeletal elements.  D) Dorsal-ventral section of an embryo through the 
forelimb illustrating the regulation of LMX1B (light green) by WNT7A (green).   
E-H) Failure of axis formation/differentiation.  E) Abrogation of AER/FGF function as 
depicted in the top panel leads to transverse defects that correspond to the time of 
disruption.  F) Progressive reduction of FGF function leads to loss of radial structures.  
G) Loss of SHH function leads to loss of ulnar-associated structures.  H) Disruption of 
LMX1B is associated with loss of dorsalization. 
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Formation and Differentiation of the Handplate 
The handplate becomes visible around the 5th week of development.  HOX 
transcription factors (particularly HOXD9-13 and HOXA9-13) and SHH interact to 
establish digit number and identity (Fig A.3 A) (48-51).  SHH also induces a posterior-
anterior (ulnar to radial) BMP gradient that has at least two roles in the formation and 
differentiation of digits.  First, BMPs induce apoptosis, or programmed cell death, within 
interdigital space.  This is accomplished, in part, by repressing FGF expression in the 
overlying AER (52-54).  Second, BMPs participate in completing digital identity via the 
phalanx forming region, a region overlying the distal digital anlagen that regulates 
chondrogenesis via SOX9 up-regulation and maintains the digit associated FGF in the 
overlying AER for continued digital outgrowth (55).  However, it is still unclear how the 
various members of the BMP family (e.g., BMP2/4/5/6/7 and GDG5/6), which are 
expressed in the digital and interdigital mesenchyme, establish periodic thresholds that 
alternate between apoptosis and chondrogenesis.   
 
Disruption of Interdigit Formation and Differentiation (Soft Tissue 
Deficiencies) 
  Several natural models of persistent interdigital webbing exist, such as ducks and 
bats (53;56).  In both animal models, the BMP inhibitor Gremlin (GREM) is expressed 
within the interdigital region, limiting apoptosis (53).  Ectopic overexpression of BMP 
inhibitors in the limb mesenchyme (57) and persistent FGF function in the AER or 
mesoderm (54;58) inhibit interdigital apoptosis and result in syndactyly.  Mutations in 
Noggin (NOG), a BMP inhibitor, are clinically associated with joint synostoses, 
syndactyly and polydactyly reflecting the spectrum of BMP functions.    
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In Apert Syndrome, the acrosyndactyly is caused by mutations in FGF receptor 2 
(FGFR2) that increase its activation affinity for FGF ligands and glycosaminoglycans 
that are diffusely present in the limb mesenchyme (41;59).  The continuous stimulation of 
the receptor generates constitutively active signaling, i.e. always on. This constant FGF 
signaling disavows interdigital BMP signals and results in complex syndactyly.     
The mechanisms that convey dorsal-ventral and digit specific ligament/tendon 
formation and attachment are less well-characterized.  Candidate genes responsible for 
flexion-contraction disorders, such as camptodactyly, may be involved in neuromuscular 
interaction and/or extracellular matrix formation (e.g. PRG4).  Further investigation is 
needed to characterize the pathogenetic basis of these hand-related soft tissue 
abnormalities. 
 
Disruption of Digit Formation and Differentiation (Skeletal 
Deficiencies) 
As described above, abrogation of SHH results in the loss of ulnar digits, a 
disruption of the radial-ulnar axis.  However, abnormalities in the SHH signaling cascade 
can also yield polydactylies.  GLI3, a transcription factor involved in SHH signaling, 
accentuates the functional gradient of SHH across the radial-ulnar axis (Fig A.3 B).  In 
the radial aspect of the limb bud, GLI3 undergoes post-transcriptional modification into a 
shortened repressor form that counters SHH action on target cells.  In the region of the 
ZPA, SHH blocks GLI3 modification to yield the full length activator form (60-62).   
Mutation of this bi-functional transcription factor can cause ulnar polydactyly (also called 
postaxial polydactyly types A & B) (63;64) and radial polydactyly (preaxial polydactyly 
type IV) with syndactyly (65).  In mice, the complete absence of GLI3 causes a loss in 
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digit identity (Fig A.3 B) (60), which is morphologically similar to the human condition 
of a five-fingered hand or a non-opposable triphalangeal thumb (66).  Additionally, 
mutations in the limb-specific SHH regulatory region cause abnormal anterior (or radial) 
expression of SHH and yield triphalangeal thumbs (67;68).   
Disruption of HOXD13 (69) or deletion of the entire HOXD9-13 region (70) 
results in variant forms of synpolydactyly, a disorder characterized by disorganized 
digit/interdigit formation and identity (Fig A.3 C).  Loss of HOXA13 function is 
associated with Hand-foot-genital Syndrome which exhibits hypoplastic middle 
phalanges and digit deviation (71;72).   
Digit formation, segmentation and cartilage maturation involve multiple factors 
and pathways.  Thus, mutation or disruption of many of these may result in shortened 
digits or brachydactyly.  Mutations in Hoxd13 can cause brachydactyly type D and E1.  
Disruption of factors involved in cartilage maturation also cause brachydactyly, including 
IHH, (type A1), BMPR1B (type A1 and A2), Gdf5 (type A2 and C), ROR2 (Type B1), 
NOG (Type B2) and PTHLH (type E2).  
During digit formation and differentiation, BMPs regulate the transition between 
digital SOX9 activation and FGF maintenance in the overlying AER.  Complete absence 
of SOX9 results in regression of the limbs since cartilage formation is not induced (73).  
Haploinsufficiency of SOX9 results in camptomelic dysplasia with reduced cartilage 
formation, bowing of long bones and brachydactyly.   
Ogino generated a model of central deficiency (cleft or split hand) (74) using the 
alkylating chemotherapeutic agent Busulfan.  For a brief window during handplate 
development, the teratogen caused increased apoptosis in the distal progress zone and 
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AER leading to central clefting, central syndactyly, and central digit duplication (Fig A.3 
D).  The increase in handplate apoptosis also resulted in disruption of AER-related FGF 
expression, reduced and irregular BMP4 expression from the AER and underlying 
mesoderm, and reduced ZPA-related SHH expression (75).  Thus, these data link the 
clefting, syndactyly, and polydactyly of central deficiency to a common, albeit 
molecularly complicated, mechanism during handplate formation.   
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Figure A.3) Disruption of Handplate Formation/Differentiation 
A) From left to right: during early handplate formation SHH and HOX transcription 
factors create a posterior to anterior gradient (ulnar-radial; purple  to peach) that 
establishes interdigital (ID) signaling centers, digital anlagen and a BMP gradient (brown 
to yellow).  The BMP gradient participates in conveying digital and ID fates via the 
phalanx forming region (PFR – fuchsia region capping digits) and repression of the AER, 
respectively (arrows).   Apoptosis in the ID region ensues with regression of the 
associated AER (stippled region).  Overlying the digit, the AER persists and outgrowth 
continues as the PFR regulates digit construction.  B) Expression pattern of SHH-related 
GLI3 expression: GLI3 repressor (GLI3r) predominates in the radial aspect of the 
developing limb, while GLI3 activator (GLI3a) surrounds the ZPA.  In the complete 
absence of GLI3 (rather than targeted mutations as in the human), the digit number is 
expanded and the unique ulnar-radial digit identity is lost generating identical “default” 
digits.  C) The nested expression pattern of HOXD9-13 is represented by HOXD9, 
HOXD11 and HOXD13.  In the absence of HOXD9-13, the hand exhibits synpolydactyly 
with excessive carpals, irregular digital elements and loss of alternating ID regions.  D)  
From left to right: The central distal region of the handplate appears to be particularly 
sensitive to disruption (cross hatched).  Teratogenic exposure can induce cell death in the 
AER (1), the ID region (2) or both (3) resulting in partial duplication (1), syndactyly (2) 
or cleft hand (3),respectively.  In all images the thumb is up.  Note - typically the central 
or third digit is the primary target for disruption with clefting and duplication.  Digit two 
(D, center and right) is used to permit a collective illustration. 
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Relationship to Classification  
The insights gained from our increasing knowledge of developmental biology do 
not align with the IFSSH/Swanson classification scheme.  During development, the 
molecular pathways that organize and define the unique asymmetries of the upper limb 
are established, i.e. the proximal-distal, anterior-posterior (or radial-ulnar) and dorsal-
ventral axes.  Disruption of these developmental pathways causes consistent 
abnormalities affecting the formation of the entire limb along these axes.  Under the 
IFSSH/Swanson classification, the conditions classified in IFSSH Group I - “Failure of 
Formation” tend to emphasize axis- related abnormalities that affect the proximal limb 
(i.e., arm and forearm) which may extend to the hand.  Consequently, it would be 
reasonable to group these conditions together into a category reflecting the etiology and 
global impact, i.e. Failure of Axis Formation/Differentiation – Entire Upper Limb, and to 
include sub-categories which indicate which axis is primarily involved. 
The conditions listed under IFSSH Group 2 “Failure of Differentiation” tend to 
emphasize abnormalities of handplate formation and differentiation, rather than 
abnormalities of differentiation alone.  Polydactyly, currently within IFSSH Group III – 
“Duplication” also involves failures of formation and differentiation affecting the 
anterior-posterior (radial-ulnar) axis.  Exclusion of polydactyly from Groups I or II 
appears illogical.  These handplate-limited malformations can be sub-categorized 
according to whether they disrupt axis formation and/or differentiation, e.g., 
polydactylies which by common definition are axial (radial-ulnar) defects, or whether 
they disrupt generalized handplate formation and/or differentiation (unspecified axis) e.g. 
syndactyly. Moreover, none of these IFSSH Groups adequately address the variety of 
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malformations evident in cleft hands, which prompted the Japanese Society of Hand 
Surgery (JSSH) to propose the addition of another group within the IFSSH/Swanson 
classification - “Abnormal Induction of Digital Rays” (76) 
IFSSH Group IV - “Overgrowth” is a descriptive term that does not convey a 
mechanism of etiology.  Similarly, IFSSH Group V - “Undergrowth” is nonspecific, 
uninformative regarding etiology, and the inclusion of disorders within the category 
appears arbitrary. Undergrowths such as brachymelia with brachydactyly or 
symbrachydactyly involve molecular pathways consistent with transverse deficiencies, 
while undergrowths such as longitudinal deficiencies are excluded from this category.   
Although IFSSH Group VII - “Generalized Skeletal Disorder” noted syndromic 
entities, as the number of defined genetic syndromes with upper limb malformations and 
diverse skeletal involvement has accumulated, it has become less meaningful to separate 
these into a separate category rather than the presenting limb morphologies.  
Our increased understanding of limb morphogenesis and dysmorphogenesis has 
accentuated problems of the IFSSH/Swanson classification and prompted surgeons, 
pathologists and geneticists working in the field of congenital limb anomalies to question 
the adequacy of this classification (4-6;8;9).   
The terminology of dysmorphology offers a framework for conveying the 
etiology of congenital limb anomalies (77).  A Malformation is an abnormal formation of 
a body part or complex tissue.  Deformation differs from a malformation as the insult 
occurs after normal formation.  A Dysplasia is an abnormality in the size, shape, and 
organization of cells within a tissue.  Dysmorphologists describe a fourth term, 
Disruption.  As this process involves alteration of tissue which is already formed, for the 
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purposes of classification, it is reasonable to include those conditions which are 
considered to be Disruptions alongside those considered to be Deformations. 
Although the pathogenesis of some specific anomalies remains obscure, the 
concept of separating malformations, deformations and dysplasias provides a sound 
structure for categorizing congenital upper limb anomalies. Therefore, to align the 
classification scheme with our current understanding of limb development at a molecular 
level using dysmorphology terminology, we recommend three broad categories – 
Malformations, Deformations and Dysplasias.  Malformations are further subdivided 
according to the axis of development which is predominantly affected and whether the 
defect involves the entire limb or restricted primarily to the hand.  Incorporation of the 
above principles results in a classification scheme as follows: 
 
I. Malformations  
I A.  Failure of Axis Formation/Differentiation – Entire Upper Limb 
To more accurately reflect the pathogenesis of many of the malformations currently 
listed under IFSSH Group 1 - “Failure of Formation” we recommend a subcategory 
entitled “Failure of Axis Formation/Differentiation – Entire Upper Limb” with three 
divisions reflecting the three axes that can be disrupted (see table A.I).  We include 
brachydactylies that impact the entire limb (Symbrachydactyly, and brachydactyly type 
B1) under defects of the proximal-distal axis together with transverse deficiencies and 
intersegmental deficiencies.  Defects of the radial-ulnar axis include not only radial and 
ulnar longitudinal deficiencies, but also radial and ulnar duplications such as ulnar 
dimelia, and radial-ulnar synostosis (previously listed under IFSSH Group III - 
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“Duplications” and IFSSH Group II - “Failure of Differentiation”, respectively).  We 
further add defects of the dorsal-ventral axis such as Nail-Patella Syndrome.  This would 
bring together malformations that alter the unique upper limb asymmetries and tend to 
have a more comprehensive effect on limb development (which may also include the 
hand).   
 
I B.  Failure of Axis Formation/Differentiation – Handplate  
Axial defects limited to the handplate are separated into the second subcategory.  
Previously, the polydactylies were considered duplication defects; however, these 
typically can be attributed to disruption of an axial signaling pathway.  For example, 
disruption of GLI3 function, a transcription factor involved in the definition of the radial-
ulnar axis, can cause preaxial polydactyly (type IV – or polysyndactyly) (78) and ulnar 
(postaxial) polydactyly (type A1) (65).     
We also include triphalangeal thumbs in this group.  Recent genetic studies of radial 
polydactyly (preaxial polydactyly type II) found point mutations in or duplications of the 
limb specific SHH regulatory region (79-81).  In animal models similar point mutations 
induce ectopic radial SHH expression and preaxial polydactyly (82-84).    
Disruption of the dorsal-ventral axis can also be limited to the handplate such as in 
dorsal dimelia; therefore such malformations are also included within this subsection. 
 
I C.  Failure of Hand Plate Formation and Differentiation – Unspecified Axis  
The malformations listed under IFSSH Group II - “Failure of Differentiation” 
involve primarily, but not exclusively, handplate development.  We have combined 
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defects limited the handplate that are not related to axis disruption under “I C”.  For 
example, abnormalities that involve the distinctly hand-associated pathways that regulate 
interdigit formation and digit/phalanx designation are placed in this category.  We also 
include malformations that probably involve multiple pathways such as synpolydactyly 
and cleft hand.  Ogino and coworkers demonstrated that a single insult to the developing 
handplate can lead to syndactyly, central polydactyly or cleft hand (74;75;85).  This 
demonstrates a link between these conditions, but not necessarily that the presence of one 
is obligatorily associated with that of the others.    
 
II.  Deformations 
According to the terminology of dysmorphology, we have established a second 
category for deformation or disruption of any portion of a limb that has already been 
formed.  Within this category “Constriction Ring Sequence” is listed which may be 
syndromic or related to amniotic banding.  Arthrogryposis or congenital contracture can 
be isolated or involve multiple joints and have several etiologies including neurological, 
muscular or connective tissue (86;87).  Arthrogryposis is also included in this category 
because the formation of contractures, typically evident during mid-gestation, occurs 
after joint and skeletal formation (88).  Trigger digits are also included as deformations 
since they typically present in childhood rather than at birth.   Deformations or 
disruptions from viral infection, vascular insults or mechanical damage do not typically 
follow a consistent pattern and, for the sake of classification, would be listed under 
subcategory D – “Not Otherwise Specified”. 
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III.  Dysplasias 
Dysplasias include conditions which have previously been listed according to 
their appearance and are a unique group associated with cellular atypia or tumor 
formation.  Limb hypertrophy which occurs in conjunction with tumor formation or 
macrodactyly which appears to be cellular dysplasia in response to some as of yet 
unknown factor are examples. These were previously classified within IFSSH Group II - 
“Failure of Differentiation” (tumorous conditions) or purely as a descriptive term within 
IFSSH Group IV - “Overgrowth”.  There may be dissent as to whether these conditions 
are in fact malformations or deformations and further insights from developmental 
biology may prompt transfer of a specific entity to either our Group I or Group II. 
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Table A.1) Comparison of the current classification scheme and proposed modifications. 
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Conclusion 
Congenital anomalies in the hand and upper limb demand a reproducible and 
consistent terminology, a universal language which allows discussion of complex clinical 
entities, indications for treatment and comparisons of results.  As our understanding of 
the molecular basis of morphogenesis and dysmorphogenesis continues to progress, the 
way that we categorize these disorders must also continue to be refined.  This 
classification may also need revisions in the future; however, we believe that the use of 
dysmorphology terminology will provide an appropriate framework to easily 
accommodate further refinements.  
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